
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Treating Transthyretin Amyloidosis via Adeno-Associated Virus Vector Delivery of Meganucleases - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="8E59B7C6926001433AB7C6002B136A9D.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="hum">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9700363/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Human Gene Therapy">
<meta name="citation_title" content="Treating Transthyretin Amyloidosis via Adeno-Associated Virus Vector Delivery of Meganucleases">
<meta name="citation_author" content="Jenny A Greig">
<meta name="citation_author_institution" content="Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.">
<meta name="citation_author" content="Camilo Breton">
<meta name="citation_author_institution" content="Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.">
<meta name="citation_author" content="Scott N Ashley">
<meta name="citation_author_institution" content="Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.">
<meta name="citation_author" content="Kelly M Martins">
<meta name="citation_author_institution" content="Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.">
<meta name="citation_author" content="Cassandra Gorsuch">
<meta name="citation_author_institution" content="Precision BioSciences, Inc., Durham, North Carolina, USA.">
<meta name="citation_author" content="Joanna K Chorazeczewski">
<meta name="citation_author_institution" content="Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.">
<meta name="citation_author" content="Thomas Furmanak">
<meta name="citation_author_institution" content="Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.">
<meta name="citation_author" content="Melanie K Smith">
<meta name="citation_author_institution" content="Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.">
<meta name="citation_author" content="Yanqing Zhu">
<meta name="citation_author_institution" content="Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.">
<meta name="citation_author" content="Peter Bell">
<meta name="citation_author_institution" content="Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.">
<meta name="citation_author" content="Wendy Shoop">
<meta name="citation_author_institution" content="Precision BioSciences, Inc., Durham, North Carolina, USA.">
<meta name="citation_author" content="Hui Li">
<meta name="citation_author_institution" content="Precision BioSciences, Inc., Durham, North Carolina, USA.">
<meta name="citation_author" content="Jeff Smith">
<meta name="citation_author_institution" content="Precision BioSciences, Inc., Durham, North Carolina, USA.">
<meta name="citation_author" content="Ginger Tomberlin">
<meta name="citation_author_institution" content="Precision BioSciences, Inc., Durham, North Carolina, USA.">
<meta name="citation_author" content="Peter Clark">
<meta name="citation_author_institution" content="Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.">
<meta name="citation_author" content="Thomas W Mitchell">
<meta name="citation_author_institution" content="Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.">
<meta name="citation_author" content="Elizabeth L Buza">
<meta name="citation_author_institution" content="Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.">
<meta name="citation_author" content="Hanying Yan">
<meta name="citation_author_institution" content="Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.">
<meta name="citation_author" content="Derek Jantz">
<meta name="citation_author_institution" content="Precision BioSciences, Inc., Durham, North Carolina, USA.">
<meta name="citation_author" content="James M Wilson">
<meta name="citation_author_institution" content="Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.">
<meta name="citation_publication_date" content="2022 Nov 14">
<meta name="citation_volume" content="33">
<meta name="citation_issue" content="21-22">
<meta name="citation_firstpage" content="1174">
<meta name="citation_doi" content="10.1089/hum.2022.061">
<meta name="citation_pmid" content="36375122">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9700363/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9700363/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9700363/pdf/hum.2022.061.pdf">
<meta name="description" content="Transthyretin amyloidosis (ATTR) is a progressive and fatal disease caused by transthyretin (TTR) amyloid fibril accumulation in tissues, which disrupts organ function. As the TTR protein is primarily synthesized by the liver, liver transplantation ...">
<meta name="og:title" content="Treating Transthyretin Amyloidosis via Adeno-Associated Virus Vector Delivery of Meganucleases">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Transthyretin amyloidosis (ATTR) is a progressive and fatal disease caused by transthyretin (TTR) amyloid fibril accumulation in tissues, which disrupts organ function. As the TTR protein is primarily synthesized by the liver, liver transplantation ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9700363/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="9700363">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1089/hum.2022.061"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/hum.2022.061.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9700363%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/9700363/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/9700363/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9700363/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-hum.png" alt="Human Gene Therapy logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Human Gene Therapy" title="Link to Human Gene Therapy" shape="default" href="https://doi.org/10.1089/hum.2022.061" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Hum Gene Ther</button></div>. 2022 Nov 14;33(21-22):1174–1186. doi: <a href="https://doi.org/10.1089/hum.2022.061" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1089/hum.2022.061</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Hum%20Gene%20Ther%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hum%20Gene%20Ther%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Hum%20Gene%20Ther%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Hum%20Gene%20Ther%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Treating Transthyretin Amyloidosis via Adeno-Associated Virus Vector Delivery of Meganucleases</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Greig%20JA%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Jenny A Greig</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Jenny A Greig</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Greig%20JA%22%5BAuthor%5D" class="usa-link"><span class="name western">Jenny A Greig</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Breton%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Camilo Breton</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Camilo Breton</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Breton%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Camilo Breton</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ashley%20SN%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Scott N Ashley</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Scott N Ashley</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ashley%20SN%22%5BAuthor%5D" class="usa-link"><span class="name western">Scott N Ashley</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Martins%20KM%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Kelly M Martins</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Kelly M Martins</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Martins%20KM%22%5BAuthor%5D" class="usa-link"><span class="name western">Kelly M Martins</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gorsuch%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Cassandra Gorsuch</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Cassandra Gorsuch</span></h3>
<div class="p">
<sup><sup>2</sup></sup>Precision BioSciences, Inc., Durham, North Carolina, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gorsuch%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Cassandra Gorsuch</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chorazeczewski%20JK%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Joanna K Chorazeczewski</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Joanna K Chorazeczewski</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chorazeczewski%20JK%22%5BAuthor%5D" class="usa-link"><span class="name western">Joanna K Chorazeczewski</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Furmanak%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Thomas Furmanak</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Thomas Furmanak</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Furmanak%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Thomas Furmanak</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Smith%20MK%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Melanie K Smith</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Melanie K Smith</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Smith%20MK%22%5BAuthor%5D" class="usa-link"><span class="name western">Melanie K Smith</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhu%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Yanqing Zhu</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Yanqing Zhu</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhu%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yanqing Zhu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bell%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Peter Bell</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Peter Bell</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bell%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Peter Bell</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shoop%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Wendy Shoop</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Wendy Shoop</span></h3>
<div class="p">
<sup><sup>2</sup></sup>Precision BioSciences, Inc., Durham, North Carolina, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shoop%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Wendy Shoop</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Hui Li</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Hui Li</span></h3>
<div class="p">
<sup><sup>2</sup></sup>Precision BioSciences, Inc., Durham, North Carolina, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hui Li</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Smith%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Jeff Smith</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Jeff Smith</span></h3>
<div class="p">
<sup><sup>2</sup></sup>Precision BioSciences, Inc., Durham, North Carolina, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Smith%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jeff Smith</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tomberlin%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Ginger Tomberlin</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Ginger Tomberlin</span></h3>
<div class="p">
<sup><sup>2</sup></sup>Precision BioSciences, Inc., Durham, North Carolina, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tomberlin%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Ginger Tomberlin</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Clark%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Peter Clark</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Peter Clark</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Clark%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Peter Clark</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mitchell%20TW%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Thomas W Mitchell</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Thomas W Mitchell</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mitchell%20TW%22%5BAuthor%5D" class="usa-link"><span class="name western">Thomas W Mitchell</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Buza%20EL%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Elizabeth L Buza</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Elizabeth L Buza</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Buza%20EL%22%5BAuthor%5D" class="usa-link"><span class="name western">Elizabeth L Buza</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yan%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">Hanying Yan</span></a><div hidden="hidden" id="id18">
<h3><span class="name western">Hanying Yan</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yan%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hanying Yan</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jantz%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id19"><span class="name western">Derek Jantz</span></a><div hidden="hidden" id="id19">
<h3><span class="name western">Derek Jantz</span></h3>
<div class="p">
<sup><sup>2</sup></sup>Precision BioSciences, Inc., Durham, North Carolina, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jantz%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Derek Jantz</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wilson%20JM%22%5BAuthor%5D" class="usa-link" aria-describedby="id20"><span class="name western">James M Wilson</span></a><div hidden="hidden" id="id20">
<h3><span class="name western">James M Wilson</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wilson%20JM%22%5BAuthor%5D" class="usa-link"><span class="name western">James M Wilson</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup><sup>1</sup></sup>Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</div>
<div id="aff2">
<sup><sup>2</sup></sup>Precision BioSciences, Inc., Durham, North Carolina, USA.</div>
<div class="author-notes p">
<div class="fn" id="corr1">
<sup><sup>*</sup></sup><p class="display-inline">Correspondence: Dr. James M. Wilson, Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, 125 South 31st Street, Suite 1200, Philadelphia, PA 19104, USA. <span>wilsonjm@upenn.edu</span></p>
</div>
<div class="fn" id="fn1"><p>
<em><sup>i</sup>ORCID ID (<a href="https://orcid.org/0000-0001-7044-3964" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://orcid.org/0000-0001-7044-3964</a>).</em>
</p></div>
<div class="fn" id="fn2"><p>
<em><sup>ii</sup>ORCID ID (<a href="https://orcid.org/0000-0002-9630-3131" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://orcid.org/0000-0002-9630-3131</a>).</em>
</p></div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2022 Mar 9; Accepted 2022 Aug 3; Issue date 2022 Nov 1.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© Jenny A. Greig <em>et al.</em> 2022; Published by Mary Ann Liebert, Inc.</div>
<p>This Open Access article is distributed under the terms of the Creative Commons License [CC-BY] (<a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC9700363  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36375122/" class="usa-link">36375122</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Transthyretin amyloidosis (ATTR) is a progressive and fatal disease caused by transthyretin (TTR) amyloid fibril accumulation in tissues, which disrupts organ function. As the TTR protein is primarily synthesized by the liver, liver transplantation can cure familial ATTR but is not an option for the predominant age-related wild-type ATTR. Approved treatment approaches include TTR stabilizers and an RNA-interference therapeutic, but these require regular re-administration. Gene editing could represent an effective one-time treatment. We evaluated adeno-associated virus (AAV) vector-delivered, gene-editing meganucleases to reduce TTR levels. We used engineered meganucleases targeting two different sites within the <em>TTR</em> gene. AAV vectors expressing TTR meganuclease transgenes were first tested in immunodeficient mice expressing the human <em>TTR</em> sequence delivered using an AAV vector and then against the endogenous <em>TTR</em> gene in rhesus macaques. Following a dose of 3 × 10<sup>13</sup> genome copies per kilogram, we detected on-target editing efficiency of up to 45% insertions and deletions (indels) in the TTR genomic DNA locus and &gt;80% indels in <em>TTR</em> RNA, with a concomitant decrease in serum TTR levels of &gt;95% in macaques. The significant reduction in serum TTR levels following <em>TTR</em> gene editing indicates that this approach could be an effective treatment for ATTR.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> transthyretin amyloidosis, transthyretin, meganuclease, AAV, gene therapy, gene editing</p></section></section><section id="s001"><h2 class="pmc_sec_title">INTRODUCTION</h2>
<p>Transthyretin amyloidosis (ATTR) is a rare, progressive fatal disease caused by accumulated transthyretin (TTR) amyloid fibrils in tissues. The tetrameric TTR protein is primarily synthesized in the liver. Dysfunctional TTR arising from mutation- or age-related issues with the wild-type protein becomes dissociated in the blood and generates misfolded monomers, which aggregate into amyloid fibrils that disrupt organ function.<sup><a href="#B1" class="usa-link" aria-describedby="B1">1</a>,<a href="#B2" class="usa-link" aria-describedby="B2">2</a></sup> The process by which wild-type TTR becomes amyloidogenic with age is not well understood. However, the aggregation of wild-type TTR predominantly presents in men over 60 years of age as cardiomyopathy.<sup><a href="#B3" class="usa-link" aria-describedby="B3">3</a></sup></p>
<p>The hereditable form of ATTR displays autosomal dominance with over 100 mutations known to result in amyloidosis.<sup><a href="#B4" class="usa-link" aria-describedby="B4">4</a>,<a href="#B5" class="usa-link" aria-describedby="B5">5</a></sup> While there is considerable phenotypic heterogeneity in clinical manifestations, hereditary ATTR primarily manifests as polyneuropathy and cardiomyopathy. The most common mutation (V30M) is associated with polyneuropathy in ATTR patients. Other symptoms can include gastrointestinal disturbances and bilateral carpal tunnel syndrome.<sup><a href="#B5" class="usa-link" aria-describedby="B5">5–7</a></sup> Genetic testing is necessary for determining the diagnosis and causative mutation. As TTR is primarily synthesized in the liver, liver transplantation can cure hereditary ATTR patients by ablating production of the circulating mutant TTR. However, organ transplantation requires immunosuppressive drugs to prevent rejection. Moreover, long-term outcomes following this procedure vary based on several factors such as the causative mutation.<sup><a href="#B8" class="usa-link" aria-describedby="B8">8</a></sup></p>
<p>An alternative treatment approach involves TTR stabilizers, including tafamidis, to prevent dissociation of tetrameric TTR into its constituent monomers.<sup><a href="#B9" class="usa-link" aria-describedby="B9">9</a></sup> While approved in the United States for the treatment of ATTR cardiomyopathy,<sup><a href="#B10" class="usa-link" aria-describedby="B10">10</a></sup> tafamidis has variable efficacy in patients with later-stage polyneuropathy and may be mutation dependent for this symptom in hereditable ATTR.<sup><a href="#B11" class="usa-link" aria-describedby="B11">11</a></sup></p>
<p>Recently, two TTR knockdown approaches have received approval for the treatment of ATTR polyneuropathy: inotersen and patisiran. These drugs have different mechanisms of action, but both knock down expression of mutant and wild-type TTR, thus making them effective for all ATTR manifestations by reducing circulating TTR by ∼80%.<sup><a href="#B12" class="usa-link" aria-describedby="B12">12</a>,<a href="#B13" class="usa-link" aria-describedby="B13">13</a></sup> However, these drugs require regular re-administration. Inotersen is an antisense oligonucleotide therapy which binds to <em>TTR</em> mRNA and targets it for degradation<sup><a href="#B14" class="usa-link" aria-describedby="B14">14</a></sup>; it requires weekly subcutaneous injections. Moreover, this drug has safety concerns such as thrombocytopenia and glomerulonephritis.<sup><a href="#B13" class="usa-link" aria-describedby="B13">13</a>,<a href="#B15" class="usa-link" aria-describedby="B15">15</a></sup> Patisiran is a small interfering RNA that also targets <em>TTR</em> mRNA for degradation and is administered intravenously every 3 weeks.<sup><a href="#B12" class="usa-link" aria-describedby="B12">12</a></sup> Since this drug is delivered via lipid nanoparticle (LNP) to the liver, patients require premedication with corticosteroids, antihistamines, and acetaminophen to prevent infusion reactions. In contrast to these alternative treatments, a gene-editing approach could provide an effective one-time therapy.</p>
<p>A gene-editing approach utilizing liver-targeted LNPs for delivery of a CRISPR-Cas9-based strategy has shown reductions of &gt;94% in TTR levels in mice and nonhuman primates (NHPs).<sup><a href="#B16" class="usa-link" aria-describedby="B16">16</a>,<a href="#B17" class="usa-link" aria-describedby="B17">17</a></sup> Interim clinical trial data from this approach were recently published in which reductions of 87% (range of 80–96%, <em>n</em> = 3 subjects) were achieved in hereditary ATTR patients at day 28 following a dose of 0.3 mg/kg.<sup><a href="#B18" class="usa-link" aria-describedby="B18">18</a></sup></p>
<p>We previously evaluated an adeno-associated virus (AAV) vector-delivered, liver-directed meganuclease for <em>in vivo</em> gene editing of the pro-protein convertase subtilisin/kexin type 9 (PCSK9) gene.<sup><a href="#B19" class="usa-link" aria-describedby="B19">19–21</a></sup> PCSK9 is an antagonist of the low-density lipoprotein (LDL) receptor, meaning that a loss of function of PCSK9 reduces LDL levels; therefore, this approach could be useful in the treatment of hypercholesterolemia. The PCSK9 meganuclease recognized and generated a double-stranded break within a specific 22 bp sequence in the <em>PCSK9</em> gene, allowing endogenous DNA repair mechanisms to generate insertions and deletions (indels) at the cleavage site that disrupted PCSK9 protein expression. Following intravenous (IV) administration of various dose levels of AAV vectors in NHPs, circulating PCSK9 levels ranged from 16% to 83% of baseline levels for over 3 years.<sup><a href="#B20" class="usa-link" aria-describedby="B20">20</a></sup></p>
<p>In this study, we evaluated an AAV-delivered, meganuclease-based, gene-editing approach to reduce TTR levels. We tested two different engineered meganucleases, each having a unique target site within the <em>TTR</em> gene. The most effective meganuclease produced a sustained &gt;95% reduction from baseline of serum TTR levels in rhesus macaques. This significant reduction in serum TTR levels following genomic editing of the <em>TTR</em> gene indicates that AAV delivery of a TTR-specific meganuclease could represent an effective treatment for ATTR.</p></section><section id="s002"><h2 class="pmc_sec_title">MATERIALS AND METHODS</h2>
<section id="s003"><h3 class="pmc_sec_title">Data availability statement</h3>
<p>All data discussed in the article are available in the main text or Supplementary Materials. Complete clinical pathology data can be obtained upon request.</p></section><section id="s004"><h3 class="pmc_sec_title">AAV vector production</h3>
<p>All AAV vectors were produced by the Penn Vector Core at the University of Pennsylvania as previously described.<sup><a href="#B22" class="usa-link" aria-describedby="B22">22</a></sup> Briefly, plasmids expressing either the M1TTR or M2TTR engineered meganucleases from the thyroxine-binding globulin (TBG) promoter, including the WPRE sequence, were packaged within the AAV8 capsid. The M1TTR meganuclease targets a site in exon 1 within the TTR gene that is conserved in mouse, NHP, and human genomes, whereas the <em>TTR</em> exon 3 target site for the M2TTR meganuclease is not present in the mouse genome but is conserved in NHPs and humans.</p></section><section id="s005"><h3 class="pmc_sec_title">Mice</h3>
<p>All animal procedures were performed in accordance with protocols approved by the Institutional Animal Care and Use Committee of the University of Pennsylvania. Male <em>Rag1</em><sup>−/−</sup> mice 6–8 weeks of age were purchased from The Jackson Laboratory (Bar Harbor, ME) and received an IV injection of 3 × 10<sup>13</sup> genome copies per kilogram (GC/kg) of AAV8.TBG.hTTR(V30M) or vehicle control (phosphate-buffered saline [PBS]) on day 0 (<em>n</em> = 5/group). On day 14, mice were IV administered 3 × 10<sup>11</sup> to 3 × 10<sup>13</sup> GC/kg of AAV8.TBG.M1TTR or AAV8.TBG.M2TTR. Mice administered M1TTR were necropsied at day 56 (<em>n</em> = 5/group) and those administered M2TTR were necropsied on days 28 (<em>n</em> = 1), 42 (<em>n</em> = 2), and 56 (<em>n</em> = 2).</p></section><section id="s006"><h3 class="pmc_sec_title">Rhesus macaques</h3>
<p>Wild-type rhesus macaques 3–6 years old (<em>n</em> = 8, one male [administered with the low dose of AAV8.TBG.M1TTR] and seven females) were obtained from Covance (Princeton, NJ). NHP studies were conducted at the University of Pennsylvania within a facility that is U.S. Department of Agriculture registered, Association for Assessment and Accreditation of Laboratory Animal Care accredited, and Public Health Service assured. As previously described,<sup><a href="#B23" class="usa-link" aria-describedby="B23">23</a></sup> animals were housed in stainless steel cages with perches. All cage sizes and housing conditions were compliant with the Guide for the Care and Use of Laboratory Animals. A 12-h light/12-h dark cycle was maintained and controlled using an Edstrom Watchdog system.</p>
<p>Animals were fed Certified Primate Diet 5048 (PMI Feeds, Inc., Brentwood, MO) twice per day (morning and evening). An additional variety of food treats that were fit for human consumption, including fruits, vegetables, nuts, and cereals, were given daily as part of the standard enrichment process. Manipulanda such as kongs, mirrors, a puzzle feeder, and raisin balls were provided daily. Animals also received visual enrichment along with human interaction on a daily basis. All interventions were performed during the light cycle, and animals were fasted overnight before being anesthetized.</p>
<p>On study day 0, macaques were administered 10 mL of vector into the saphenous vein at a rate of 1 mL/min using an infusion pump (Harvard Apparatus, Holliston, MA). Two macaques each received a dose of 6 × 10<sup>12</sup> and 3 × 10<sup>13</sup> GC/kg of AAV8.TBG.M1TTR or AAV8.TBG.M2TTR (<em>n</em> = 2/dose/vector). From vector-administration day through weeks 8–12, all NHPs received prednisolone at a dose of 1 mg/kg/day orally, after which animals were tapered off prednisolone by gradual reduction of the daily dose.</p></section><section id="s007"><h3 class="pmc_sec_title">Analysis during the in-life phase</h3>
<p>We anesthetized rhesus macaques and collected blood samples on selected days using the femoral vein. Antech (Irvine, CA) performed complete blood counts, clinical chemistries, and coagulation panels on the blood samples. Neutralizing antibody (NAb) titers were determined on serum samples taken before initiation of the study and throughout the in-life phase, as described previously.<sup><a href="#B24" class="usa-link" aria-describedby="B24">24</a>,<a href="#B25" class="usa-link" aria-describedby="B25">25</a></sup> Macaques were also screened for the presence of the meganuclease target sites before vector administration on DNA extracted from peripheral blood mononuclear cells.</p></section><section id="s008"><h3 class="pmc_sec_title">Liver biopsy</h3>
<p>On days 18 and 128 post-vector administration, a mini laparotomy procedure was performed to isolate liver tissue. Collected samples were divided into those for histopathology (<em>i.e.</em>, fixed in 10% neutral buffered formalin) or biodistribution (<em>i.e.</em>, frozen on dry ice and stored at −60°C or colder).</p></section><section id="s009"><h3 class="pmc_sec_title">Detection of TTR in serum</h3>
<p>Blood was collected in serum separator tubes, allowed to clot, and serum was isolated. We analyzed mouse serum samples for both endogenous mouse levels and human TTR levels derived from the AAV8.TBG.hTTR(V30M) vector using enzyme-linked immunosorbent assay (ELISA) in accordance with the manufacturer's instructions. We determined mouse and human TTR levels using the Prealbumin ELISA Kit (mouse) from AVIVA Systems Biology (San Diego, CA) and PreAlbumin (TTR) ELISA Kit from Abcam (Cambridge, United Kingdom), respectively.</p>
<p>Charles River Laboratories quantitated the intact NHP TTR protein in serum using mass spectrometric immunoassay microcolumns (Thermo Fisher) and ultra-high-performance liquid chromatography–high-resolution mass spectrometry with a Q-Exactive Orbitrap mass spectrometer.</p></section><section id="s010"><h3 class="pmc_sec_title">Using next-generation sequencing for on- and off-target analysis</h3>
<p>For on-target analysis of DNA extracted from mouse liver samples, we evaluated the indel % in the region of interest using Amplicon-Seq as previously described.<sup><a href="#B19" class="usa-link" aria-describedby="B19">19–21</a></sup> Briefly, the region of interest within <em>TTR</em> exon 1 for M1TTR and exon 3 for M2TTR was amplified by polymerase chain reaction (PCR). We then generated next-generation sequencing (NGS) libraries from the PCR product, which were sequenced on a MiSeq instrument (Illumina, San Diego, CA). These sequences were then mapped to a reference genome (Assembly GRCm38.p6). Using a custom script, we quantified unedited reads and reads containing indels.<sup><a href="#B19" class="usa-link" aria-describedby="B19">19–21</a></sup> The same analysis was performed for RNA, which was reverse transcribed to cDNA using random primers.</p>
<p>For NHP samples, we quantified AAV integration and translocations in addition to indels by AMP-Seq.<sup><a href="#B19" class="usa-link" aria-describedby="B19">19–21</a>,<a href="#B26" class="usa-link" aria-describedby="B26">26</a></sup> Briefly, DNA was purified and sheared using a ME220 focused-ultrasonicator (Covaris, Woburn, MA) and purified with Agencourt AMPure XP beads (Beckman Coulter, Brea, CA). Fragments were end-repaired, A-tailed, and ligated to special adapters. We generated NGS libraries by two rounds of nested PCR using either the negative or positive primers. Libraries were sequenced on a MiSeq instrument, and the resulting sequences were mapped to a reference genome (Mmul_8.0.1 for rhesus macaque) and the administered AAV vector genome. We used a custom script to characterize and quantify edited alleles, as previously reported.<sup><a href="#B19" class="usa-link" aria-describedby="B19">19–21</a></sup></p>
<p>To evaluate off-targets in NHP samples, we performed inverted terminal repeat (ITR)-Seq.<sup><a href="#B27" class="usa-link" aria-describedby="B27">27</a></sup> Briefly, this unbiased genome-wide detection of off-targets was performed on purified liver DNA that was sheared using a ME220 focused ultrasonicator, end-repaired, A-tailed, and ligated to special adapters as described for AMP-Seq. Using AAV-ITR and adapter-specific primers, we amplified ITR-containing DNA fragments and generated NGS-compatible libraries. DNA was sequenced on a MiSeq instrument and the obtained reads were mapped to the rhesus macaque reference genome and the administered AAV vector genome. We used a custom script to identify off-target sites from the mapped reads, as previously described.<sup><a href="#B27" class="usa-link" aria-describedby="B27">27</a></sup> A subset of genomic regions identified as off-target sites by ITR-Seq were sequenced by Amplicon-Seq; we then determined the indel %.</p></section><section id="s011"><h3 class="pmc_sec_title">Vector GC and transgene RNA analysis</h3>
<p>Liver samples were snap-frozen at the time of biopsy or necropsy; we extracted DNA using the QIAamp DNA Mini Kit (Qiagen, Valencia, CA). DNase-treated total RNA was isolated from 100 mg of tissue. We quantified RNA by spectrophotometry, and aliquots were reverse transcribed to cDNA using random primers. We detected and quantified vector GC in extracted DNA and relative meganuclease transcript expression in extracted RNA using real-time PCR, as described previously.<sup><a href="#B23" class="usa-link" aria-describedby="B23">23</a>,<a href="#B28" class="usa-link" aria-describedby="B28">28</a></sup> Briefly, vector GC and RNA levels were quantified using primers and probes designed against a vector-specific sequence, respectively.</p></section><section id="s012"><h3 class="pmc_sec_title">
<em>In situ</em> hybridization and immunohistochemistry</h3>
<p>Liver samples were fixed in 10% neutral buffered formalin and used to determine meganuclease expression by <em>in situ</em> hybridization (ISH) and immunohistochemistry (IHC). IHC was performed on sections obtained from formalin-fixed, paraffin-embedded liver samples. Sections were deparaffinized through a xylene and ethanol series followed by antigen retrieval using a pressure cooker (TintoRetriever Pressure Cooker; Bio SB) with 1 × Antigen Unmasking Solution (Vector Labs H-3300); boiling time was set to 20 min. We then treated the sections sequentially with 2% H<sub>2</sub>O<sub>2</sub> (15 min; Sigma), avidin/biotin blocking reagents (15 min each; Vector Laboratories), and blocking buffer (1% donkey serum in PBS +0.2% Triton for 15 min) before incubating the sections with primary (45 min at 37°C) and biotinylated secondary antibodies (30 min at 37°C). The primary rabbit antibody against the meganuclease was provided by Precision BioSciences and used at a 1:2,000 dilution. Secondary antibody biotinylated donkey anti-rabbit antibodies were used at a 1:500 dilution (Jackson ImmunoResearch). All antibodies were diluted in 1% donkey serum.</p>
<p>After incubation, slides were washed in PBS, and a VECTASTAIN Elite ABC Kit (Vector Laboratories) was used according to the manufacturer's instructions with 3,3-diaminobenzidine as substrate to stain-bound antibodies. Sections were dehydrated through ethanol and xylene, and coverslips were applied.</p>
<p>Sections from formalin-fixed, paraffin-embedded liver tissues were used for ISH with the ViewRNA ISH Tissue Assay Kit (Life Technologies) according to the manufacturer's protocol. Z-shaped probe pairs binding to the meganuclease RNA were synthesized by the kit manufacturer. We visualized the location of hybridized probe sequences by the deposition of Fast Red substrate, which we imaged with a fluorescence microscope using a rhodamine filter set. Sections were counterstained with DAPI (4′,6-diamidino-2-phenylindole) to visualize nuclei.</p>
<p>We performed hematoxylin and eosin staining on sections from paraffin-embedded liver biopsy samples. Processing and staining procedures were conducted according to standard protocols. Liver sections were evaluated by a board-certified veterinary pathologist.</p></section><section id="s013"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p>We used linear mixed-effect modeling to evaluate significant differences in serum TTR levels over time. We compared mouse <em>TTR</em> RNA from individual groups using the Wilcoxon rank-sum test. On selected off-target sites, we statistically analyzed indel % using Fisher's Exact test to detect significant differences between peripheral blood mononuclear cells isolated before vector administration (Pre) and day 18 and Pre and day 128. All values are presented as mean ± standard error of the mean. A <em>p</em>-value of &lt;0.05 was considered significant.</p></section></section><section id="s014"><h2 class="pmc_sec_title">RESULTS</h2>
<section id="s015"><h3 class="pmc_sec_title">Reduction in serum TTR levels following gene editing in mice with a meganuclease that targets both murine and human <em>TTR</em>
</h3>
<p>We first evaluated the M1TTR meganuclease that targets a site that is conserved in mouse, NHP, and human genomes. To determine its editing potential on the mouse and human TTR sequences, we first administered an AAV8 vector expressing the V30M mutant version of the human <em>TTR</em> gene as a transgene. A similar strategy was previously employed to evaluate gene editing of the human <em>PCSK9</em> gene in mice.<sup><a href="#B19" class="usa-link" aria-describedby="B19">19</a>,<a href="#B21" class="usa-link" aria-describedby="B21">21</a></sup></p>
<p>Immunodeficient male <em>Rag1</em><sup>−/−</sup> mice were administered 3 × 10<sup>13</sup> GC/kg of AAV8.TBG.hTTR(V30M) or vehicle control on day 0. Fourteen days later, mice were administered 3 × 10<sup>11</sup>, 3 × 10<sup>12</sup>, or 3 × 10<sup>13</sup> GC/kg of AAV8.TBG.M1TTR or vehicle. Blood was collected throughout the in-life phase for evaluation of both mouse (<a href="#f1" class="usa-link">Fig. 1A</a>) and human (<a href="#f1" class="usa-link">Fig. 1B</a>) serum TTR protein levels, presented as percent of baseline TTR levels calculated from the average of the day 14 values. Mice administered vehicle or the lowest dose of vector expressing the meganuclease (3 × 10<sup>11</sup> GC/kg) did not show any change in baseline mouse TTR levels (<a href="#f1" class="usa-link">Fig. 1A</a>). The mid and high doses of meganuclease vector (3 × 10<sup>12</sup> and 3 × 10<sup>13</sup> GC/kg) showed a significant reduction in mouse TTR levels of 63% and 79%, respectively; this effect was not influenced by preadministration with the AAV8.TBG.hTTR(V30M) expression vector or vehicle (<a href="#f1" class="usa-link">Fig. 1A</a>, <em>p</em> &lt; 0.001).</p>
<figure class="fig xbox font-sm" id="f1"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9700363_hum.2022.061_figure1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a50d/9700363/8912ddbaa067/hum.2022.061_figure1.jpg" loading="lazy" height="724" width="780" alt="Figure 1."></a></p>
<div class="p text-right font-secondary"><a href="figure/f1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Dose-dependent editing and reduction in serum TTR levels following <em>in vivo</em> gene editing with a meganuclease that targets both mouse and human <em>TTR</em>. Male <em>Rag1<sup>−/−</sup></em> mice were IV administered with 3 × 10<sup>13</sup> GC/kg of AAV8.TBG.hTTR(V30M) or vehicle control on day 0 (<em>n</em> = 5/group). On day 14, mice were IV administered with 3 × 10<sup>11</sup>, 3 × 10<sup>12</sup>, and 3 × 10<sup>13</sup> GC/kg of AAV8.TBG.M1TTR or vehicle control. Blood was collected at selected time points for serum mouse <strong>(A)</strong> and human TTR levels <strong>(B)</strong>, respectively. <em>Dashed line</em> indicates time of meganuclease vector administration (day 14). Percentage of baseline TTR levels was calculated using the average of day 14. Mice were necropsied on day 56. <strong>(C)</strong> Liver was harvested at necropsy for evaluation of indel % in mouse gDNA, the AAV genome (AAV DNA), and human <em>TTR</em> RNA derived from the first vector (AAV RNA). <strong>(D)</strong> Evaluation of relative expression of mouse <em>TTR</em> RNA transcript. Values presented as mean ± SEM. *<em>p</em> &lt; 0.05, **<em>p</em> &lt; 0.001. AAV, adeno-associated virus; GC, genome copy; gDNA, genomic DNA; hTTR, human transthyretin; indel; insertion and deletion; IV, intravenous; SEM, standard error of the mean; TTR, transthyretin.</p></figcaption></figure><p>Preadministration of the AAV8.TBG.hTTR(V30M) expression vector enabled evaluation of the editing potential of the M1TTR meganuclease for the human <em>TTR</em> gene. In mice administered 3 × 10<sup>13</sup> GC/kg of AAV8.TBG.hTTR(V30M) on day 0 and then vehicle on day 14, expression of human TTR continued to increase to peak expression at day 28 and then plateaued at 113% of baseline by day 56 (<a href="#f1" class="usa-link">Fig. 1B</a>). Following administration of 3 × 10<sup>11</sup>, 3 × 10<sup>12</sup>, and 3 × 10<sup>13</sup> GC/kg of the meganuclease vector, there was a dose-dependent decrease in human TTR levels to 50%, 33%, and &lt;1% of baseline by day 56, respectively (<a href="#f1" class="usa-link">Fig. 1B</a>).</p></section><section id="s016"><h3 class="pmc_sec_title">Dose-dependent editing in both mouse genomic and vector DNA and RNA following <em>in vivo</em> gene editing</h3>
<p>At day 56, mice were necropsied and livers harvested for evaluation of indels in (i) mouse genomic DNA (denoted as gDNA in <a href="#f1" class="usa-link">Fig. 1C</a>); (ii) the AAV vector genome (AAV DNA); and (iii) the human <em>TTR</em> RNA derived from the AAV8.TBG.hTTR(V30M) expression vector (AAV RNA, <a href="#f1" class="usa-link">Fig. 1C</a>). We observed only 5–10% indels in gDNA, AAV DNA, and AAV RNA in mice that received the lowest dose of meganuclease vector (3 × 10<sup>11</sup> GC/kg). We saw indels of 50–53% across the mouse genomic DNA, AAV DNA, and AAV RNA for mice that received 3 × 10<sup>12</sup> GC/kg. By contrast, mice administered 3 × 10<sup>13</sup> GC/kg had 56–59% indels in the DNA analyses, with 80% indels observed in the vector-derived RNA (<a href="#f1" class="usa-link">Fig. 1C</a>). Indels were nearly identical (∼56%) in the mouse genome of animals administered either the AAV8.TBG.hTTR(V30M) expression vector or vehicle before 3 × 10<sup>13</sup> GC/kg of the meganuclease vector. When we characterized the indels seen with the M1TTR meganuclease in both the gDNA and AAV DNA, we observed that the most common indel was a 1 bp deletion (data not shown).</p>
<p>We also evaluated changes in the relative expression of mouse <em>TTR</em> RNA where a dose-dependent decrease from an 18% reduction at the lowest meganuclease vector dose to a 70% reduction following administration of 3 × 10<sup>13</sup> GC/kg was detected (<a href="#f1" class="usa-link">Fig. 1D</a>). We attributed the reduction in RNA levels to transcription of indels in the DNA sequence resulting in reduced expression and/or increased RNA degradation.</p></section><section id="s017"><h3 class="pmc_sec_title">Enhanced editing efficiency with a meganuclease targeting an alternative site within the TTR gene</h3>
<p>An alternative engineered meganuclease—M2TTR—was designed to target a different sequence within the TTR gene compared to that of the M1TTR meganuclease. The target site for the M2TTR meganuclease is not present in the mouse genome but is conserved between NHPs and humans. To evaluate the <em>in vivo</em> efficacy of this meganuclease, we preadministered immunodeficient male <em>Rag1</em><sup>−/−</sup> mice with 3 × 10<sup>13</sup> GC/kg of AAV8.TBG.hTTR(V30M) to supply the human <em>TTR</em> sequence on day 0. Blood was collected throughout the in-life phase for evaluation of human serum TTR levels (<a href="#f2" class="usa-link">Fig. 2A</a>). We presented these levels as percent of baseline TTR levels calculated from the average of the day 14 values. Expression of human TTR in mice administered vehicle rather than a vector expressing the meganuclease rose to a peak of 117% of baseline at day 21 post-vector administration. Expression then decreased to 31% of baseline by day 56 (<a href="#f2" class="usa-link">Fig. 2A</a>). There was a significant dose-dependent decrease in human TTR levels of 94.5%, 99.8%, and 99.9% following IV administration of 3 × 10<sup>11</sup>, 3 × 10<sup>12</sup>, and 3 × 10<sup>13</sup> GC/kg of AAV8.TBG.M2TTR, respectively (<a href="#f2" class="usa-link">Fig. 2A</a>, <em>p</em> &lt; 0.001).</p>
<figure class="fig xbox font-sm" id="f2"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9700363_hum.2022.061_figure2.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a50d/9700363/0d8e24f7657f/hum.2022.061_figure2.jpg" loading="lazy" height="625" width="750" alt="Figure 2."></a></p>
<div class="p text-right font-secondary"><a href="figure/f2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Gene editing of human <em>TTR</em> in mice results in reduced serum human TTR levels. Male <em>Rag1<sup>−</sup></em><sup>/<em>−</em></sup> mice were IV administered 3 × 10<sup>13</sup> GC/kg AAV8.TBG.hTTR(V30M) on day 0 (<em>n</em> = 5 per group). On day 14, mice were IV administered 3 × 10<sup>11</sup>, 3 × 10<sup>12</sup>, or 3 × 10<sup>13</sup> GC/kg AAV8.TBG.M2TTR. Blood was collected at selected time points for human TTR levels <strong>(A)</strong>. <em>Dashed line</em> indicates time of meganuclease vector administration (day 14). We calculated the percentage of baseline TTR levels using the average of day 14. Mice were necropsied on days 28 (<em>n</em> = 1), 42 (<em>n</em> = 2), and 56 (<em>n</em> = 2). <strong>(B)</strong> Livers were harvested at necropsy for evaluation of indel % in the AAV genome (DNA) and human TTR RNA derived from the first vector (RNA). Values presented as mean ± SEM. *<em>p</em> &lt; 0.001.</p></figcaption></figure><p>At day 56, mice were necropsied and livers harvested for evaluation of indel % in the AAV vector genome and in the human <em>TTR</em> RNA derived from the AAV8.TBG.hTTR(V30M) expression vector (<a href="#f2" class="usa-link">Fig. 2B</a>). Again, there was a clear dose-dependent increase in gene editing within the AAV-supplied human <em>TTR</em> sequence at both the DNA and RNA level with up to 66% and 91% editing, respectively, at day 56 following a dose of 3 × 10<sup>13</sup> GC/kg of AAV8.TBG.M2TTR. While the indel percentage increased over time for the low- and mid-dose groups, mice administered the highest dose of the meganuclease-expressing vector (3 × 10<sup>13</sup> GC/kg) did not change from day 28 through day 56, suggesting maximal editing efficiency was achieved early in the study (<a href="#f2" class="usa-link">Fig. 2B</a>).</p></section><section id="s018"><h3 class="pmc_sec_title">Translation of gene editing potential from mice to NHPs</h3>
<p>The same engineered meganucleases (M1TTR and M2TTR) were then evaluated in rhesus macaques to determine the translatability of gene-editing efficacy. Rhesus macaques were IV administered 6 × 10<sup>12</sup> or 3 × 10<sup>13</sup> GC/kg of AAV8 vector expressing either the M1TTR or M2TTR meganuclease. All NHPs received prednisolone at a dose of 1 mg/kg/day orally for 8–12 weeks post-vector administration, at which point animals were tapered off prednisolone by a gradual reduction of daily dose. Liver biopsies were performed on day 18 and approximately day 128 post-vector administration to evaluate the indel frequency in the <em>TTR</em> locus of NHP genomic DNA and RNA by AMP-Seq and Amplicon-Seq, respectively, as well as off-targets by ITR-Seq (<a href="#f3" class="usa-link">Fig. 3</a>).</p>
<figure class="fig xbox font-sm" id="f3"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9700363_hum.2022.061_figure3.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a50d/9700363/02a90ba2c912/hum.2022.061_figure3.jpg" loading="lazy" height="1078" width="777" alt="Figure 3."></a></p>
<div class="p text-right font-secondary"><a href="figure/f3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Translation of TTR gene editing from mice to NHPs. Rhesus macaques were IV administered 6 × 10<sup>12</sup> and 3 × 10<sup>13</sup> GC/kg of AAV8.TBG.M1TTR or AAV8.TBG.M2TTR. We performed liver biopsies on day 18 and 128 postvector administration. Animals administered with AAV8.TBG.M1TTR were necropsied 1-year postvector administration. We extracted DNA and RNA and performed NGS analysis, including AMP-Seq on DNA <strong>(A)</strong>, Amplicon-Seq on RNA <strong>(B)</strong>, and ITR-Seq on DNA <strong>(C)</strong>. ITR, inverted terminal repeat; NGS, next-generation sequencing; NHP, nonhuman primate.</p></figcaption></figure><p>During the in-life phase of the study, NHPs were routinely monitored by blood draws for complete blood cell counts and serum chemistries. Some of the NHPs receiving either vector exhibited peaks in aspartate transaminase or alanine aminotransferase levels that mostly coincided with the time of the liver biopsy procedure (see <a href="#SD1" class="usa-link">Supplementary Fig. S1</a> for NHPs administered AAV8.TBG.M1TTR and <a href="#SD2" class="usa-link">Supplementary Fig. S2</a> for NHPs administered AAV8.TBG.M2TTR). Anti-AAV8 NAbs were also measured throughout the in-life phase for NHPs administered AAV8.TBG.M2TTR (<a href="#SD3" class="usa-link">Supplementary Fig. S3</a>).</p>
<p>Assessment of editing in genomic DNA extracted from liver samples was performed by AMP-Seq, which evaluated insertions, deletions, ITR-integration (integration of vector sequences), and translocations (<a href="#f3" class="usa-link">Fig. 3A</a>). Macaques administered the M1TTR meganuclease had an average of 7% and 16% editing in genomic DNA on day 18 following administration of 6 × 10<sup>12</sup> or 3 × 10<sup>13</sup> GC/kg vector, respectively (<a href="#f3" class="usa-link">Fig. 3A</a>). Similarly, we observed a limited degree of editing in the <em>TTR</em> RNA of 2.5% and 7% at the low and high vector doses (<a href="#f3" class="usa-link">Fig. 3B</a>). Similar to our observations in mice, the indels generated by the M1TTR meganuclease in genomic DNA predominantly comprised a 1 bp deletion (<a href="#SD4" class="usa-link">Supplementary Fig. S4</a>). Following this low level of on-target editing, the off-targets detected for this meganuclease constituted fewer than 22 unique sites across the time points evaluated (<a href="#f3" class="usa-link">Fig. 3C</a>).</p>
<p>In comparison, macaques administered vector expressing the M2TTR meganuclease showed high efficacy with little-to-no dose effect (<a href="#f3" class="usa-link">Fig. 3</a>). This observation excludes the reduced efficacy seen in one macaque administered the low dose of 6 × 10<sup>12</sup> GC/kg of AAV8.TBG.M2TTR (26% editing in genomic DNA and 21% in RNA, <a href="#f3" class="usa-link">Fig. 3A, B</a>). NHPs administered AAV8.TBG.M2TTR showed 43% and 42% editing at day 18 in the genomic DNA and 84% and 80% editing in RNA at the low- and high-vector doses, respectively (<a href="#f3" class="usa-link">Fig. 3A, B</a>). This editing efficacy persisted between the two liver biopsy time points (day 18 and 128).</p>
<p>While the editing efficiency was slightly reduced from mice to NHPs at the RNA level following administration of 3 × 10<sup>13</sup> GC/kg AAV8.TBG.M2TTR (91% in mice [<a href="#f2" class="usa-link">Fig. 2B</a>] vs. 80% in macaques [<a href="#f3" class="usa-link">Fig. 3B</a>]), these data illustrate more efficient translation between species for this vector-administered gene-editing approach than is usually seen for gene therapy-based applications. After characterizing the M2TTR indels, we found that this meganuclease resulted in similar levels of 2 and 3 bp deletions (<a href="#SD5" class="usa-link">Supplementary Fig. S5</a>); a 3 bp deletion predominated in the <em>TTR</em> RNA (<a href="#SD6" class="usa-link">Supplementary Fig. S6</a>).</p>
<p>The M2TTR meganuclease generated relatively few off-target events, as detected through ITR-Seq, in conjunction with its high-efficiency on-target editing activity (<a href="#f3" class="usa-link">Fig. 3C</a>). There was an average of 37 unique off-target sites across all NHPs injected with this meganuclease, with a maximum of 76 sites being detected in a single NHP. These off-target sites occurred more frequently within genes (&gt;65%) than in intergenic regions, with a bias toward genes that are highly expressed in the liver (<a href="#SD7" class="usa-link">Supplementary Fig. S7</a>).</p>
<p>We further validated the M2TTR off-target sites in the liver, in comparison to DNA extracted from peripheral blood mononuclear cells harvested before vector administration (<a href="#tb1" class="usa-link">Table 1</a>). We amplified and sequenced the 19 top-ranking off-target sites identified by the ITR-Seq analysis to evaluate differences between day 18 and/or 128 and before vector administration (Pre). Statistically significant differences between Pre samples and either day 18 or 128 or between day 18 and 128 were evaluated by Fisher's Exact test (<em>p</em> &lt; 0.05, <a href="#tb1" class="usa-link">Table 1</a>). The number of off-target sites reduced from day 18 to 128 on average (from 37 to 16 unique sites), similar to that observed for the M2PCSK9 meganuclease.<sup><a href="#B19" class="usa-link" aria-describedby="B19">19–21</a></sup> One of the off-target sites (chr8:11196161–11196201) had an average of 2.4% indels (range of 0.37–3.72% on day 18 post-vector administration, <a href="#tb1" class="usa-link">Table 1</a>). The most likely off-target sequence in this region shares 19/22 bp homology to the target site for the M2TTR meganuclease, but the site is not conserved in the human genome.</p>
<section class="tw xbox font-sm" id="tb1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>
Off-target validation in liver after systemic administration of AAV8.TBG.M2TTR
</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
</colgroup>
<thead>
<tr>
<th rowspan="3" align="left" valign="bottom" colspan="1"> </th>
<th colspan="6" align="center" valign="bottom" rowspan="1">6 × 10<sup>12</sup> GC/kg<hr>
</th>
<th colspan="6" align="center" valign="bottom" rowspan="1">3 × 10<sup>13</sup> GC/kg<hr>
</th>
</tr>
<tr>
<th colspan="3" align="center" valign="bottom" rowspan="1">1305048<hr>
</th>
<th colspan="3" align="center" valign="bottom" rowspan="1">1404128<hr>
</th>
<th colspan="3" align="center" valign="bottom" rowspan="1">1305168<hr>
</th>
<th colspan="3" align="center" valign="bottom" rowspan="1">T1466224<hr>
</th>
</tr>
<tr>
<th align="center" valign="bottom" colspan="1" rowspan="1">Pre</th>
<th align="center" valign="bottom" colspan="1" rowspan="1">d18</th>
<th align="center" valign="bottom" colspan="1" rowspan="1">d128</th>
<th align="center" valign="bottom" colspan="1" rowspan="1">Pre</th>
<th align="center" valign="bottom" colspan="1" rowspan="1">d18</th>
<th align="center" valign="bottom" colspan="1" rowspan="1">d128</th>
<th align="center" valign="bottom" colspan="1" rowspan="1">Pre</th>
<th align="center" valign="bottom" colspan="1" rowspan="1">d18</th>
<th align="center" valign="bottom" colspan="1" rowspan="1">d128</th>
<th align="center" valign="bottom" colspan="1" rowspan="1">Pre</th>
<th align="center" valign="bottom" colspan="1" rowspan="1">d18</th>
<th align="center" valign="bottom" colspan="1" rowspan="1">d128</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="bottom" colspan="1" rowspan="1">chr12:87904928-87904968</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.09</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.32</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.09<sup><a href="#tf2" class="usa-link">*</a></sup>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.10</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>1.21</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.51<sup><a href="#tf2" class="usa-link">*</a></sup></strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.09</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>1.03</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.83<sup><a href="#tf2" class="usa-link">*</a></sup></strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.10</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.27</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.36<sup><a href="#tf2" class="usa-link">*</a></sup></strong>
</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="1" rowspan="1">chr8:11196161-11196201</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.21</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.37</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.18<sup><a href="#tf2" class="usa-link">*</a></sup></strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.41</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>3.72</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>2.41<sup><a href="#tf2" class="usa-link">*</a></sup></strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.23</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>3.22</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>3.78<sup><a href="#tf2" class="usa-link">*</a></sup></strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.13</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>2.35</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>1.42<sup><a href="#tf2" class="usa-link">*</a></sup></strong>
</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="1" rowspan="1">chr5:37071902-37071942</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.10</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05<sup><a href="#tf2" class="usa-link">*</a></sup>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.27</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.19<sup><a href="#tf2" class="usa-link">*</a></sup></strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.45</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.36<sup><a href="#tf2" class="usa-link">*</a></sup></strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.29</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.18<sup><a href="#tf2" class="usa-link">*</a></sup></strong>
</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="1" rowspan="1">chr16:45654359-45654399</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.04</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.06</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.03<sup><a href="#tf2" class="usa-link">*</a></sup>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.03</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.11</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.15<sup><a href="#tf2" class="usa-link">*</a></sup></strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.03</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.08</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.10</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.03</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.16</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.06<sup><a href="#tf2" class="usa-link">*</a></sup></strong>
</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="1" rowspan="1">chr1:131368022-131368062</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.11</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.11</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.12</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.10</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.07</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.08<sup><a href="#tf2" class="usa-link">*</a></sup></strong>
</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="1" rowspan="1">chr5:65826942-65826982</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.08</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.04</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.17</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.04<sup><a href="#tf2" class="usa-link">*</a></sup>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.00</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.20</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.20</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.04</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.15</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.08<sup><a href="#tf2" class="usa-link">*</a></sup></strong>
</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="1" rowspan="1">chr2:95972521-95972562</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.04</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.04</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.04</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.08</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05<sup><a href="#tf2" class="usa-link">*</a></sup>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.11</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.04<sup><a href="#tf2" class="usa-link">*</a></sup>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="1" rowspan="1">chr6:1350225-1350265</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.08<sup><a href="#tf2" class="usa-link">*</a></sup></strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.24</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.07<sup><a href="#tf2" class="usa-link">*</a></sup></strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.30</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.41<sup><a href="#tf2" class="usa-link">*</a></sup></strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.17</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05<sup><a href="#tf2" class="usa-link">*</a></sup>
</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="1" rowspan="1">chr5:54623831-54623871</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.09</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.04<sup><a href="#tf2" class="usa-link">*</a></sup>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.20</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.17</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.03</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.25</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.19<sup><a href="#tf2" class="usa-link">*</a></sup></strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.18</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.07<sup><a href="#tf2" class="usa-link">*</a></sup>
</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="1" rowspan="1">chr2:40480165-40480205</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.10</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.07<sup><a href="#tf2" class="usa-link">*</a></sup></strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.12</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.11</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.07</strong>
</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="1" rowspan="1">chr16:75546540-75546581</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.04</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.03</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.04</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.04</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.09</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.03<sup><a href="#tf2" class="usa-link">*</a></sup>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.03</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.03</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.03</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.04</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.04</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="1" rowspan="1">chr4:38395097-38395136</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.03</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.04</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.03</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.03</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.03</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.03</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.03</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.08</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.05<sup><a href="#tf2" class="usa-link">*</a></sup></strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.03</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.04</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.03</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="1" rowspan="1">chr17:74722587-74722627</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.07</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.07</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.07</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.07</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.38</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.21<sup><a href="#tf2" class="usa-link">*</a></sup></strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.09</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.33</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.25<sup><a href="#tf2" class="usa-link">*</a></sup></strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.07</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.15</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.14</strong>
</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="1" rowspan="1">chr16:26937570-26937610</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.08</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.08</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.07</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.07</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.07</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.07</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.08</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.10</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.07<sup><a href="#tf2" class="usa-link">*</a></sup>
</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="1" rowspan="1">chr15:27727216-27727256</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.04</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.04</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="1" rowspan="1">chr7:56260476-56260515</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.07</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.07</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.11</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.09</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.10</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.07<sup><a href="#tf2" class="usa-link">*</a></sup>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.08</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.08</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.11<sup><a href="#tf2" class="usa-link">*</a></sup></strong>
</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="1" rowspan="1">chr11:122161601-122161640</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.07</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.10</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.08<sup><a href="#tf2" class="usa-link">*</a></sup>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.07</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.08</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.08</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.08</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.13</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.12</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.10</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.16</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.12<sup><a href="#tf2" class="usa-link">*</a></sup></strong>
</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="1" rowspan="1">chr1:54693640-54693689</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.13</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.10</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.08</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.15</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.16</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.09</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.10</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.09</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.11</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.12</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.14</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="1" rowspan="1">chr13:55676638-55676677</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.08</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.07</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.09</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.11</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.07<sup><a href="#tf2" class="usa-link">*</a></sup>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.08</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.12</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.13</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.07</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">
<strong>0.14</strong>
</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.09<sup><a href="#tf2" class="usa-link">*</a></sup>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tb1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="tf1"><p>Rhesus macaques were IV administered 6 × 10<sup>12</sup> or 3 × 10<sup>13</sup> GC/kg of AAV8.TBG.M2TTR. We performed liver biopsies on day 18 (d18) and day 128 (d128) postvector administration. We extracted DNA from liver biopsy samples and PMBCs isolated before vector administration (Pre). We sequenced a subset of genomic regions identified as off-target sites by ITR-Seq and evaluated the indel %. Fisher's Exact test (<em>p</em> &lt; 0.05) was used to perform statistical analysis. Bold typeface indicates significant differences between Pre and d18 and Pre and d128.</p></div>
<div class="fn" id="tf2">
<sup>
<sup>*</sup>
</sup><p class="display-inline">Indicates significant differences between day 18 and day 128.</p>
</div>
<div class="fn" id="tf3"><p>GC, genome copies; indel; insertion and deletion; IV, intravenous; ITR, inverted terminal repeat.</p></div>
</div></section><p>We also evaluated the serum TTR levels in NHPs injected with the M2TTR meganuclease-expressing vector (<a href="#f4" class="usa-link">Fig. 4</a>). Both macaques administered the high-vector dose (3 × 10<sup>13</sup> GC/kg) had a &gt;95% reduction in serum TTR levels. One of the NHPs administered 6 × 10<sup>12</sup> GC/kg had a decrease in serum TTR levels to 9% of baseline, whereas the other macaque dosed at 6 × 10<sup>12</sup> GC/kg had an average plateau level of 61% of baseline (<a href="#f4" class="usa-link">Fig. 4</a>). When vector GC and meganuclease RNA transcript levels were evaluated on liver samples taken at biopsy, we found that the macaque with the partial reduction in serum TTR levels exhibited the lowest vector GC and RNA levels in the liver (<a href="#tb2" class="usa-link">Table 2</a>), suggesting reduced gene-transfer efficiency.</p>
<figure class="fig xbox font-sm" id="f4"><h4 class="obj_head">Figure 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9700363_hum.2022.061_figure4.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a50d/9700363/c9e76296021d/hum.2022.061_figure4.jpg" loading="lazy" height="572" width="792" alt="Figure 4."></a></p>
<div class="p text-right font-secondary"><a href="figure/f4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Substantial reduction in serum TTR levels in NHPs following systemic administration of AAV8.TBG.M2TTR. Rhesus macaques were IV administered 6 × 10<sup>12</sup> or 3 × 10<sup>13</sup> GC/kg of AAV8.TBG.M2TTR. We collected blood samples at selected time points for TTR levels, which are presented as percent of baseline levels.</p></figcaption></figure><section class="tw xbox font-sm" id="tb2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>
Liver vector genome copies and meganuclease RNA levels in liver following systemic administration of AAV8.TBG.M1TTR or AAV8.TBG.M2TTR
</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
</colgroup>
<thead><tr>
<th align="left" valign="bottom" colspan="1" rowspan="1">Vector</th>
<th align="center" valign="bottom" colspan="1" rowspan="1">NHP ID</th>
<th align="center" valign="bottom" colspan="1" rowspan="1">Dose, GC/kg</th>
<th align="center" valign="bottom" colspan="1" rowspan="1">Study day</th>
<th align="center" valign="bottom" colspan="1" rowspan="1">Vector GC/μg DNA</th>
<th align="center" valign="bottom" colspan="1" rowspan="1">Vector GC/diploid genome</th>
<th align="center" valign="bottom" colspan="1" rowspan="1">Transcript RNA/100 ng</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="3" align="left" valign="bottom" colspan="1">AAV8.TBG.M1TTR</td>
<td rowspan="3" align="left" valign="bottom" colspan="1">RA3330</td>
<td rowspan="3" align="left" valign="bottom" colspan="1">6.00E+12</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">18</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">2.64E+06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">13.20</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">3.37E+06</td>
</tr>
<tr>
<td align="center" valign="bottom" colspan="1" rowspan="1">128</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">1.18E+06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">5.89</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">1.44E+04</td>
</tr>
<tr>
<td align="center" valign="bottom" colspan="1" rowspan="1">364</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">8.31E+04</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.42</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">6.60E+02</td>
</tr>
<tr>
<td rowspan="3" align="left" valign="bottom" colspan="1">AAV8.TBG.M1TTR</td>
<td rowspan="3" align="left" valign="bottom" colspan="1">RA3385</td>
<td rowspan="3" align="left" valign="bottom" colspan="1">6.00E+12</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">18</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">1.83E+06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">9.14</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">6.72E+05</td>
</tr>
<tr>
<td align="center" valign="bottom" colspan="1" rowspan="1">128</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">1.45E+06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">7.27</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">5.55E+03</td>
</tr>
<tr>
<td align="center" valign="bottom" colspan="1" rowspan="1">364</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">1.19E+05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.59</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">2.53E+02</td>
</tr>
<tr>
<td rowspan="3" align="left" valign="bottom" colspan="1">AAV8.TBG.M1TTR</td>
<td rowspan="3" align="left" valign="bottom" colspan="1">15D003</td>
<td rowspan="3" align="left" valign="bottom" colspan="1">3.00E+13</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">18</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">1.72E+07</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">85.94</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">3.59E+06</td>
</tr>
<tr>
<td align="center" valign="bottom" colspan="1" rowspan="1">128</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">3.69E+06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">18.44</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">8.55E+04</td>
</tr>
<tr>
<td align="center" valign="bottom" colspan="1" rowspan="1">364</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">3.51E+05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">1.75</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">2.02E+03</td>
</tr>
<tr>
<td rowspan="3" align="left" valign="bottom" colspan="1">AAV8.TBG.M1TTR</td>
<td rowspan="3" align="left" valign="bottom" colspan="1">15D020</td>
<td rowspan="3" align="left" valign="bottom" colspan="1">3.00E+13</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">18</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">1.23E+07</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">61.62</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">2.62E+06</td>
</tr>
<tr>
<td align="center" valign="bottom" colspan="1" rowspan="1">128</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">2.78E+06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">13.90</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">4.91E+04</td>
</tr>
<tr>
<td align="center" valign="bottom" colspan="1" rowspan="1">364</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">1.18E+05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.59</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">1.95E+03</td>
</tr>
<tr>
<td rowspan="2" align="left" valign="bottom" colspan="1">AAV8.TBG.M2TTR</td>
<td rowspan="2" align="center" valign="bottom" colspan="1">1305048</td>
<td rowspan="2" align="left" valign="bottom" colspan="1">6.00E+12</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">18</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">1.77E+06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">8.84</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">1.68E+05</td>
</tr>
<tr>
<td align="center" valign="bottom" colspan="1" rowspan="1">130</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">2.46E+05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">1.23</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">3.68E+03</td>
</tr>
<tr>
<td rowspan="2" align="left" valign="bottom" colspan="1">AAV8.TBG.M2TTR</td>
<td rowspan="2" align="center" valign="bottom" colspan="1">1404128</td>
<td rowspan="2" align="left" valign="bottom" colspan="1">6.00E+12</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">18</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">1.92E+06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">9.59</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">4.35E+05</td>
</tr>
<tr>
<td align="center" valign="bottom" colspan="1" rowspan="1">137</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">1.49E+05</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">0.75</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">2.64E+04</td>
</tr>
<tr>
<td rowspan="2" align="left" valign="bottom" colspan="1">AAV8.TBG.M2TTR</td>
<td rowspan="2" align="center" valign="bottom" colspan="1">1305168</td>
<td rowspan="2" align="left" valign="bottom" colspan="1">3.00E+13</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">18</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">8.00E+06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">40.02</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">3.66E+05</td>
</tr>
<tr>
<td align="center" valign="bottom" colspan="1" rowspan="1">130</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">1.60E+06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">8.01</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">9.04E+04</td>
</tr>
<tr>
<td rowspan="2" align="left" valign="bottom" colspan="1">AAV8.TBG.M2TTR</td>
<td rowspan="2" align="left" valign="bottom" colspan="1">T1466224</td>
<td rowspan="2" align="left" valign="bottom" colspan="1">3.00E+13</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">18</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">1.76E+07</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">88.13</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">5.05E+05</td>
</tr>
<tr>
<td align="center" valign="bottom" colspan="1" rowspan="1">140</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">1.30E+06</td>
<td align="center" valign="bottom" colspan="1" rowspan="1">6.51</td>
<td align="left" valign="bottom" colspan="1" rowspan="1">3.90E+04</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tb2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="tf4"><p>Rhesus macaques were IV administered 6 × 10<sup>12</sup> or 3 × 10<sup>13</sup> GC/kg AAV8.TBG.M1TTR or AAV8.TBG.M2TTR. We performed liver biopsies on day 18 and 128 postvector administration. Animals administered AAV8.TBG.M1TTR were necropsied 1-year postvector administration. We extracted DNA and RNA and determined vector GCs and meganuclease RNA levels.</p></div>
<div class="fn" id="tf5"><p>NHP, nonhuman primate.</p></div>
</div></section><p>We also evaluated the liver biopsy samples from macaques administered AAV8.TBG.M2TTR for meganuclease expression at both the RNA and protein levels by ISH and IHC, respectively (<a href="#SD8" class="usa-link">Supplementary Fig. S8</a>). We detected M2TTR meganuclease RNA and protein expression following either vector dose at day 18 postvector administration. Protein expression was undetectable by day 128 via IHC, however, consistent with previous observations of other meganuclease-expressing vectors.<sup><a href="#B19" class="usa-link" aria-describedby="B19">19–21</a></sup> We also evaluated <a href="#s008" class="usa-link">liver biopsy</a> sections for histopathology by a board-certified veterinary pathologist (<a href="#SD9" class="usa-link">Supplementary Fig. S9</a>). While there were reports of mononuclear cell infiltrates, these were minimal. The only other finding was a mild cytoplasmic hepatocellular vacuolation noted in one animal administered the high vector dose.</p></section></section><section id="s019"><h2 class="pmc_sec_title">DISCUSSION</h2>
<p>We evaluated an AAV-delivered, meganuclease-based, gene-editing approach to reduce TTR levels as a potential treatment for ATTR. In this study, the selection of engineered meganucleases as the gene-editing platform enabled the administration of a single AAV to achieve editing of the <em>TTR</em> gene. This was possible because the M1TTR and M2TTR meganuclease coding sequences are small and easily packaged within a single AAV genome, with the M1TTR and M2TTR meganucleases being expressed from a single transcript. Our initial experiments were performed in immunodeficient mice to evaluate meganucleases that targeted sites within the mouse and/or human genome by providing the human <em>TTR</em> sequence expressed from an AAV vector and subsequent administration with meganuclease-expressing AAV vectors.</p>
<p>The M1TTR meganuclease demonstrated editing in both the endogenous mouse genomic <em>TTR</em> sequence and the exogenous human <em>TTR</em> transgene sequence supplied via AAV vector to similar levels across the dose range evaluated. The vector containing the human <em>TTR</em> sequence was dosed at 3 × 10<sup>13</sup> GC/kg, which resulted in almost all hepatocytes being transduced with an average of 9 vector GC per cell. This high transduction likely resulted in the similar level of editing of both the endogenous mouse genomic <em>TTR</em> sequence and the exogenous human <em>TTR</em> sequence as they were both present in the same number of cells. While the lowest vector dose (3 × 10<sup>11</sup> GC/kg) resulted in 10% indels in mouse genomic DNA (<a href="#f1" class="usa-link">Fig. 1C</a>) and an 18% reduction in mouse <em>TTR</em> RNA levels (<a href="#f1" class="usa-link">Fig. 1D</a>), we did not detect any change in mouse TTR levels (<a href="#f1" class="usa-link">Fig. 1A</a>). The same dose led to AAV-derived DNA and RNA editing by 4.6% and 6.5%, respectively (<a href="#f1" class="usa-link">Fig. 1C</a>), which, in turn, reduced vector-derived human TTR levels by 50%. This suggests possible differences in editing potential for genomic (mouse) and (likely) episomal (<em>i.e.</em>, human <em>TTR</em> derived from an AAV vector) DNA, endogenous mouse RNA stability and/or degradation compared to vector-derived RNA, and/or issues related to differences in assay sensitivity in the mouse and human TTR ELISA. While this meganuclease was generally less effective throughout our studies, the conservation of its target site through mice, NHPs, and humans enabled us to evaluate the translatability of this therapeutic strategy across three species.</p>
<p>To evaluate the M2TTR meganuclease in mice—whose target site is absent in the mouse genome—we relied on a strategy used previously to evaluate gene editing in the human <em>PCSK9</em> gene in mice.<sup><a href="#B19" class="usa-link" aria-describedby="B19">19</a>,<a href="#B21" class="usa-link" aria-describedby="B21">21</a></sup> Following preadministration of AAV8.TBG.hTTR(V30M) to provide the NHP and human-conserved meganuclease target site, all three doses of AAV8.TBG.M2TTR led to &gt;94% reductions in hTTR levels derived from the AAV vector. A clearer dose–response was seen at the DNA and RNA levels, with up to 65% editing in the h<em>TTR</em> sequence supplied by the vector and &gt;90% editing in the vector-derived RNA sequence.</p>
<p>In the subsequent study, we systemically administered this vector to rhesus macaques. The high level, short-term expression of the meganuclease from this approach resulted in an on-target editing efficiency of up to 45% indels in the <em>TTR</em> genomic DNA locus and &gt;80% indels in <em>TTR</em> RNA following a dose of 3 × 10<sup>13</sup> GC/kg. This appears to be consistent with reported hepatocyte transduction efficiencies in NHPs of 70–80% on day 17 following administration of 3 × 10<sup>13</sup> GC/kg of an AAV8 vector expressing a meganuclease targeting <em>PCSK9</em>.<sup><a href="#B19" class="usa-link" aria-describedby="B19">19</a></sup> There was persistence of editing between the two liver biopsy time points, and there was a concomitant decrease in serum TTR levels of &gt;95% in both animals administered this vector dose.</p>
<p>We did not see a consistent response in NHPs at the lower dose of AAV8.TBG.M2TTR vector (6 × 10<sup>12</sup> GC/kg). One macaque (NHP ID 1404128) had an average TTR plateau of 9% (similar to macaques administered the fivefold higher dose) compared to 61% of baseline for the other macaque (NHP ID 1305048). NHP 1305048 showed reduced efficacy across all parameters following the same dose of 6 × 10<sup>12</sup> GC/kg, including a 1.7- and 4.1-fold reduction in DNA and RNA editing at day 18, respectively (<a href="#f3" class="usa-link">Fig. 3A, B</a>), and a 2.6-fold reduction in nuclease RNA levels (<a href="#tb2" class="usa-link">Table 2</a>). A potential explanation for this difference is differential vector gene transfer in the liver either based on the number of hepatocytes transduced or by the level of gene transfer per cell (as suggested by lower RNA levels in this animal). However, the exact reason(s) for this difference is unclear.</p>
<p>Reduced gene transfer following systemic administration typically occurs due to NAbs interacting with the vector capsid.<sup><a href="#B29" class="usa-link" aria-describedby="B29">29</a></sup> All macaques were screened as seronegative for anti-AAV8 NAbs (NAb titer &lt;1/5) within 1 month before vector administration.<sup><a href="#B24" class="usa-link" aria-describedby="B24">24</a>,<a href="#B25" class="usa-link" aria-describedby="B25">25</a></sup> On the day of injection, 3/4 macaques had a NAb titer of 1/5 (<a href="#SD3" class="usa-link">Supplementary Fig. S3</a>). Natural fluctuations in AAV8 NAb titers in noninjected animals have been previously described.<sup><a href="#B30" class="usa-link" aria-describedby="B30">30</a></sup> While both low-dose animals had a NAb titer of 1/5 on day 0, there was a difference in the magnitude of their response by day 28 (<a href="#SD3" class="usa-link">Supplementary Fig. S3</a>). At 4 weeks post-vector administration, the macaque with the reduced editing efficacy (1305048) had a NAb titer of 1/1280, compared to a titer of 1/80 in the other low-dose animal. This larger NAb response at day 28 suggests a rebounding B cell memory response to the AAV8 capsid, which may have reduced vector transduction and efficacy in this macaque.</p>
<p>For the two NHPs administered 3 × 10<sup>13</sup> GC/kg of AAV8.TBG.M2TTR, we observed an average of 42% indels in genomic DNA, which correlated with 80% editing in <em>TTR</em> RNA, and a reduction in serum TTR levels to 4% of baseline. After characterizing the M2TTR indels, we found that this meganuclease generated similar levels of 2 and 3 bp deletions in genomic DNA (<a href="#SD5" class="usa-link">Supplementary Fig. S5</a>), with a 3 bp deletion predominating in <em>TTR</em> RNA (<a href="#SD6" class="usa-link">Supplementary Fig. S6</a>).</p>
<p>In addition to evaluating on-target efficacy, we performed an extensive and unbiased genome-wide detection of off-targets. We previously used this strategy to evaluate a meganuclease targeted to the <em>PCSK9</em> gene locus from an AAV vector.<sup><a href="#B19" class="usa-link" aria-describedby="B19">19–21</a>,<a href="#B27" class="usa-link" aria-describedby="B27">27</a></sup> Compared to the previously evaluated M2PCSK9 meganuclease used for editing within the <em>PCSK9</em> gene, the M2TTR meganuclease had off-target events equivalent to some of the self-targeting and short-promoter vectors developed to increase specificity and reduce off-targets without losing efficacy.<sup><a href="#B21" class="usa-link" aria-describedby="B21">21</a></sup> Therefore, methods to reduce off-targets by reducing meganuclease expression may be unnecessary for the M2TTR meganuclease.</p>
<p>We observed ∼3% indels in an identified off-target site for the M2TTR meganuclease. This site corresponds to an intergenic region in the rhesus macaque genome, meaning the chances of inadvertently affecting the expression of a gene are low. Furthermore, the risk associated with editing this region is likely limited to rhesus macaques, as this off-target sequence is not found in the human genome. While evaluation of off-target activity in NHPs is helpful to predict potential off-target activity in humans, studies in human cells and/or humanized mice would be required.<sup><a href="#B20" class="usa-link" aria-describedby="B20">20</a></sup> The dose of AAV8.TBG.M2TTR used in a human clinical trial could also be reduced from those evaluated here as we observed &gt;95% reductions in TTR levels at 3 × 10<sup>13</sup> GC/kg. Indeed, current treatment approaches achieve clinically meaningful outcomes when TTR is reduced by 80%.<sup><a href="#B12" class="usa-link" aria-describedby="B12">12</a>,<a href="#B13" class="usa-link" aria-describedby="B13">13</a></sup> Reducing the vector dose to decrease both on- and off-target efficacy would enhance the safety profile of this approach while retaining its therapeutic efficacy.</p>
<p>While TTR knockdown approaches by either antisense oligonucleotide therapy or RNA interference have recently gained approval for the treatment of ATTR, both approaches have limitations. Inotersen requires weekly administration and routine monitoring for adverse events.<sup><a href="#B13" class="usa-link" aria-describedby="B13">13</a>,<a href="#B15" class="usa-link" aria-describedby="B15">15</a></sup> Patisiran is administered every 3 weeks IV following a significant premedication protocol to prevent infusion reactions.<sup><a href="#B12" class="usa-link" aria-describedby="B12">12</a></sup> Attempts are underway to increase the duration of action of the RNA interference approach with vutrisiran, which is currently in phase 3 clinical trials and is administered quarterly using subcutaneous injection.<sup><a href="#B31" class="usa-link" aria-describedby="B31">31</a></sup></p>
<p>In comparison, a gene-editing approach could provide an effective one-time treatment. Another gene-editing approach utilizing liver-targeted LNPs for delivery of a CRISPR-Cas9-based strategy has shown similar reductions of &gt;94% in TTR levels in mice and NHPs.<sup><a href="#B16" class="usa-link" aria-describedby="B16">16</a>,<a href="#B17" class="usa-link" aria-describedby="B17">17</a></sup> Interim clinical trial data from this approach were recently published in which reductions of 87% (range of 80–96%, <em>n</em> = 3 subjects) were achieved in hereditary ATTR patients at day 28 following a dose of 0.3 mg/kg.<sup><a href="#B18" class="usa-link" aria-describedby="B18">18</a></sup> As with other LNP-based treatments, this approach also required preadministration of glucocorticoids and anti-histamines; one patient in the trial had an infusion reaction. By delivering the M2TTR nuclease through an AAV vector, our approach capitalizes upon the established safety profile of gene therapy vectors and, similar to our previously published results, the expression of the nuclease is not sustained.<sup><a href="#B19" class="usa-link" aria-describedby="B19">19–21</a></sup> Although using this approach for patients with ATTR would require screening for the presence of preexisting NAbs to the vector capsid, this approach results in stable genome editing up to 3 years post-vector administration in NHPs with a similar meganuclease.<sup><a href="#B20" class="usa-link" aria-describedby="B20">20</a></sup> We conclude that the significant reduction in serum TTR levels following genomic editing of the <em>TTR</em> gene indicates that AAV delivery of a TTR-specific meganuclease could represent an effective treatment for ATTR.</p></section><section id="sec20"><h2 class="pmc_sec_title">Supplementary Material</h2>
<section class="sm xbox font-sm" id="SD1"><div class="caption p"><span>Supplemental data</span></div>
<div class="media p" id="d15868e2570"><div class="caption">
<a href="/articles/instance/9700363/bin/Supp_FigS1.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supp_FigS1.pdf</a><sup> (462.1KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD2"><div class="caption p"><span>Supplemental data</span></div>
<div class="media p" id="d15868e2574"><div class="caption">
<a href="/articles/instance/9700363/bin/Supp_FigS2.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supp_FigS2.pdf</a><sup> (516.4KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD3"><div class="caption p"><span>Supplemental data</span></div>
<div class="media p" id="d15868e2578"><div class="caption">
<a href="/articles/instance/9700363/bin/Supp_FigS3.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supp_FigS3.pdf</a><sup> (376.1KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD4"><div class="caption p"><span>Supplemental data</span></div>
<div class="media p" id="d15868e2582"><div class="caption">
<a href="/articles/instance/9700363/bin/Supp_FigS4.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supp_FigS4.pdf</a><sup> (450.5KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD5"><div class="caption p"><span>Supplemental data</span></div>
<div class="media p" id="d15868e2586"><div class="caption">
<a href="/articles/instance/9700363/bin/Supp_FigS5.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supp_FigS5.pdf</a><sup> (416KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD6"><div class="caption p"><span>Supplemental data</span></div>
<div class="media p" id="d15868e2590"><div class="caption">
<a href="/articles/instance/9700363/bin/Supp_FigS6.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supp_FigS6.pdf</a><sup> (400.7KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD7"><div class="caption p"><span>Supplemental data</span></div>
<div class="media p" id="d15868e2594"><div class="caption">
<a href="/articles/instance/9700363/bin/Supp_FigS7.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supp_FigS7.pdf</a><sup> (656.4KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD8"><div class="caption p"><span>Supplemental data</span></div>
<div class="media p" id="d15868e2598"><div class="caption">
<a href="/articles/instance/9700363/bin/Supp_FigS8.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supp_FigS8.pdf</a><sup> (532.5KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD9"><div class="caption p"><span>Supplemental data</span></div>
<div class="media p" id="d15868e2602"><div class="caption">
<a href="/articles/instance/9700363/bin/Supp_FigS9.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supp_FigS9.pdf</a><sup> (675.4KB, pdf) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">ACKNOWLEDGMENTS</h2>
<p>The authors thank Penn Vector Core, Program in Comparative Medicine, Nucleic Acid Technologies Core, Immunology Core, and Histology Core at the Gene Therapy Program. The authors thank Nathan Denton for assistance with article preparation and graphics. In addition, the authors thank Alexa N. Avitto, Rucha Fadnavis, and Matthew Jennis for their continued support of this project.</p></section><section id="s020"><h2 class="pmc_sec_title">AUTHORs' CONTRIBUTIONS</h2>
<p>J.A.G.—conceptualization, investigation, methodology, supervision, writing-original, writing-revision and edits; C.B.—formal analysis, investigation, methodology, software, supervision, writing-review and edits; S.N.A.—investigation; K.M.M.—formal analysis, investigation; C.G.—conceptualization, investigation, methodology; J.K.C.—investigation; T.F.—investigation; M.K.S.—investigation, project administration; Y.Z.—investigation; P.B.—investigation; W.S.—investigation; H.L.—investigation; J.S.—investigation; G.T.—investigation; P.C.—formal analysis, investigation, software; T.W.M.—formal analysis; E.L.B.—formal analysis; H.Y.—formal analysis; D.J.—conceptualization, methodology; J.M.W.—conceptualization, funding acquisition, methodology, supervision, writing-review and edits.</p></section><section id="s021"><h2 class="pmc_sec_title">AUTHOR DISCLOSURE</h2>
<p>The authors declare having potential competing financial interests. J.M.W. is a paid advisor to and holds equity in iECURE, Scout Bio, Passage Bio, and the Center for Breakthrough Medicines (CBM). He also holds equity in the G2 Bio-associated asset companies. He has sponsored research agreements with Amicus Therapeutics, Biogen, CBM, Elaaj Bio, FA212, G2 Bio, G2 Bio-associated asset companies, iECURE, Janssen, Passage Bio, and Scout Bio, which are licensees of Penn technology. J.M.W. and J.A.G. are inventors on patents that have been licensed to various biopharmaceutical companies and for which they may receive payments. C.G., W.S., H.L., J.S., G.T., and D.J. are all paid employees of Precision BioSciences.</p></section><section id="s022"><h2 class="pmc_sec_title">FUNDING INFORMATION</h2>
<p>This research was supported by Precision BioSciences, developers of the ARCUS<sup>®</sup> genome editing platform and the engineered meganucleases used in this study.</p></section><section id="s023"><h2 class="pmc_sec_title">SUPPLEMENTARY MATERIAL</h2>
<p>
<a href="#SD1" class="usa-link">Supplementary Figure S1</a>
</p>
<p>
<a href="#SD2" class="usa-link">Supplementary Figure S2</a>
</p>
<p>
<a href="#SD3" class="usa-link">Supplementary Figure S3</a>
</p>
<p>
<a href="#SD4" class="usa-link">Supplementary Figure S4</a>
</p>
<p>
<a href="#SD5" class="usa-link">Supplementary Figure S5</a>
</p>
<p>
<a href="#SD6" class="usa-link">Supplementary Figure S6</a>
</p>
<p>
<a href="#SD7" class="usa-link">Supplementary Figure S7</a>
</p>
<p>
<a href="#SD8" class="usa-link">Supplementary Figure S8</a>
</p>
<p>
<a href="#SD9" class="usa-link">Supplementary Figure S9</a>
</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">REFERENCES</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1">
<span class="label">1.</span><cite>
Hawkins PN, Ando Y, Dispenzeri A, et al. 
Evolving landscape in the management of transthyretin amyloidosis. Ann Med
2015;47(8):625–638; doi: 10.3109/07853890.2015.1068949.</cite> [<a href="https://doi.org/10.3109/07853890.2015.1068949" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4720049/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26611723/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Med&amp;title=Evolving%20landscape%20in%20the%20management%20of%20transthyretin%20amyloidosis&amp;volume=47&amp;issue=8&amp;publication_year=2015&amp;pages=625-638&amp;pmid=26611723&amp;doi=10.3109/07853890.2015.1068949&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2">
<span class="label">2.</span><cite>
Gertz MA, Mauermann ML, Grogan M, et al.  Advances in the treatment of hereditary transthyretin amyloidosis: A review. Brain Behav
2019;9(9):e01371; doi: 10.1002/brb3.1371.</cite> [<a href="https://doi.org/10.1002/brb3.1371" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6749475/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31368669/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Behav&amp;volume=9&amp;publication_year=2019&amp;pmid=31368669&amp;doi=10.1002/brb3.1371&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3">
<span class="label">3.</span><cite>
Connors LH, Sam F, Skinner M, et al. 
Heart failure resulting from age-related cardiac amyloid disease associated with wild-type transthyretin: A prospective, observational cohort study. Circulation
2016;133(3):282–290; doi: 10.1161/CIRCULATIONAHA.115.018852.</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.115.018852" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4718760/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26660282/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Heart%20failure%20resulting%20from%20age-related%20cardiac%20amyloid%20disease%20associated%20with%20wild-type%20transthyretin:%20A%20prospective,%20observational%20cohort%20study&amp;volume=133&amp;issue=3&amp;publication_year=2016&amp;pages=282-290&amp;pmid=26660282&amp;doi=10.1161/CIRCULATIONAHA.115.018852&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4">
<span class="label">4.</span><cite>
Coelho T, Maurer MS, Suhr OB. THAOS—The Transthyretin Amyloidosis Outcomes Survey: Initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis. Curr Med Res Opin
2013;29(1):63–76; doi: 10.1185/03007995.2012.754348.</cite> [<a href="https://doi.org/10.1185/03007995.2012.754348" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23193944/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Med%20Res%20Opin&amp;title=THAOS%E2%80%94The%20Transthyretin%20Amyloidosis%20Outcomes%20Survey:%20Initial%20report%20on%20clinical%20manifestations%20in%20patients%20with%20hereditary%20and%20wild-type%20transthyretin%20amyloidosis&amp;volume=29&amp;issue=1&amp;publication_year=2013&amp;pages=63-76&amp;pmid=23193944&amp;doi=10.1185/03007995.2012.754348&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5">
<span class="label">5.</span><cite>
Maurer MS, Hanna M, Grogan M, et al. 
Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey). J Am Coll Cardiol
2016;68(2):161–172; doi: 10.1016/j.jacc.2016.03.596.</cite> [<a href="https://doi.org/10.1016/j.jacc.2016.03.596" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4940135/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27386769/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Coll%20Cardiol&amp;title=Genotype%20and%20phenotype%20of%20transthyretin%20cardiac%20amyloidosis:%20THAOS%20(Transthyretin%20Amyloid%20Outcome%20Survey)&amp;volume=68&amp;issue=2&amp;publication_year=2016&amp;pages=161-172&amp;pmid=27386769&amp;doi=10.1016/j.jacc.2016.03.596&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6">
<span class="label">6.</span><cite>
Carr AS, Pelayo-Negro AL, Evans MR, et al. 
A study of the neuropathy associated with transthyretin amyloidosis (ATTR) in the UK. J Neurol Neurosurg Psychiatry
2016;87(6):620–627; doi: 10.1136/jnnp-2015-310907.</cite> [<a href="https://doi.org/10.1136/jnnp-2015-310907" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26243339/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neurol%20Neurosurg%20Psychiatry&amp;title=A%20study%20of%20the%20neuropathy%20associated%20with%20transthyretin%20amyloidosis%20(ATTR)%20in%20the%20UK&amp;volume=87&amp;issue=6&amp;publication_year=2016&amp;pages=620-627&amp;pmid=26243339&amp;doi=10.1136/jnnp-2015-310907&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7">
<span class="label">7.</span><cite>
Conceicao I, Gonzalez-Duarte A, Obici L, et al. 
“Red-flag” symptom clusters in transthyretin familial amyloid polyneuropathy. J Peripher Nerv Syst
2016;21(1):5–9; doi: 10.1111/jns.12153.</cite> [<a href="https://doi.org/10.1111/jns.12153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4788142/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26663427/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Peripher%20Nerv%20Syst&amp;title=%E2%80%9CRed-flag%E2%80%9D%20symptom%20clusters%20in%20transthyretin%20familial%20amyloid%20polyneuropathy&amp;volume=21&amp;issue=1&amp;publication_year=2016&amp;pages=5-9&amp;pmid=26663427&amp;doi=10.1111/jns.12153&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8">
<span class="label">8.</span><cite>
Carvalho A, Rocha A, Lobato L. Liver transplantation in transthyretin amyloidosis: Issues and challenges. Liver Transpl
2015;21(3):282–292; doi: 10.1002/lt.24058.</cite> [<a href="https://doi.org/10.1002/lt.24058" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25482846/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Liver%20Transpl&amp;title=Liver%20transplantation%20in%20transthyretin%20amyloidosis:%20Issues%20and%20challenges&amp;volume=21&amp;issue=3&amp;publication_year=2015&amp;pages=282-292&amp;pmid=25482846&amp;doi=10.1002/lt.24058&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9">
<span class="label">9.</span><cite>
Bulawa CE, Connelly S, Devit M, et al. 
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proc Natl Acad Sci U S A
2012;109(24):9629–9634; doi: 10.1073/pnas.1121005109.</cite> [<a href="https://doi.org/10.1073/pnas.1121005109" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3386102/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22645360/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&amp;title=Tafamidis,%20a%20potent%20and%20selective%20transthyretin%20kinetic%20stabilizer%20that%20inhibits%20the%20amyloid%20cascade&amp;volume=109&amp;issue=24&amp;publication_year=2012&amp;pages=9629-9634&amp;pmid=22645360&amp;doi=10.1073/pnas.1121005109&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10">
<span class="label">10.</span><cite>
Maurer MS, Schwartz JH, Gundapaneni B, et al. 
Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med
2018;379:1007–1016; DOI: 10.1056/NEJMoa1805689.</cite> [<a href="https://doi.org/10.1056/NEJMoa1805689" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30145929/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Tafamidis%20treatment%20for%20patients%20with%20transthyretin%20amyloid%20cardiomyopathy&amp;volume=379&amp;publication_year=2018&amp;pages=1007-1016&amp;pmid=30145929&amp;doi=10.1056/NEJMoa1805689&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11">
<span class="label">11.</span><cite>
Coelho T, Maia LF, da Silva AM, et al. 
Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy. J Neurol
2013;260(11):2802–2814; doi: 10.1007/s00415-013-7051-7.</cite> [<a href="https://doi.org/10.1007/s00415-013-7051-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3825212/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23974642/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neurol&amp;title=Long-term%20effects%20of%20tafamidis%20for%20the%20treatment%20of%20transthyretin%20familial%20amyloid%20polyneuropathy&amp;volume=260&amp;issue=11&amp;publication_year=2013&amp;pages=2802-2814&amp;pmid=23974642&amp;doi=10.1007/s00415-013-7051-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12">
<span class="label">12.</span><cite>
Adams D, Gonzalez-Duarte A, O'Riordan WD, et al. 
Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med
2018;379:11–21; DOI: 10.1056/NEJMoa1716153.</cite> [<a href="https://doi.org/10.1056/NEJMoa1716153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29972753/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Patisiran,%20an%20RNAi%20therapeutic,%20for%20hereditary%20transthyretin%20amyloidosis&amp;volume=379&amp;publication_year=2018&amp;pages=11-21&amp;pmid=29972753&amp;doi=10.1056/NEJMoa1716153&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13">
<span class="label">13.</span><cite>
Brannagan TH, Wang AK, Coelho T, et al. 
Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: A 2-year update from the open-label extension of the NEURO-TTR trial. Eur J Neurol
2020;27(8):1374–1381; doi: 10.1111/ene.14285.</cite> [<a href="https://doi.org/10.1111/ene.14285" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7496583/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32343462/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Neurol&amp;title=Early%20data%20on%20long-term%20efficacy%20and%20safety%20of%20inotersen%20in%20patients%20with%20hereditary%20transthyretin%20amyloidosis:%20A%202-year%20update%20from%20the%20open-label%20extension%20of%20the%20NEURO-TTR%20trial&amp;volume=27&amp;issue=8&amp;publication_year=2020&amp;pages=1374-1381&amp;pmid=32343462&amp;doi=10.1111/ene.14285&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14">
<span class="label">14.</span><cite>
Ackermann EJ, Guo S, Benson MD, et al. 
Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotides. Amyloid
2016;23(3):148–157; doi: 10.1080/13506129.2016.1191458.</cite> [<a href="https://doi.org/10.1080/13506129.2016.1191458" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27355239/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=Suppressing%20transthyretin%20production%20in%20mice,%20monkeys%20and%20humans%20using%202nd-Generation%20antisense%20oligonucleotides&amp;volume=23&amp;issue=3&amp;publication_year=2016&amp;pages=148-157&amp;pmid=27355239&amp;doi=10.1080/13506129.2016.1191458&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15">
<span class="label">15.</span><cite>
Benson MD, Waddington-Cruz M, Berk JL, et al. 
Inotersen treatment for patients with hereditary transthyretin amyloidosis. N Engl J Med
2018;379:22–31; DOI: 10.1056/NEJMoa1716793.</cite> [<a href="https://doi.org/10.1056/NEJMoa1716793" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12611561/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29972757/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Inotersen%20treatment%20for%20patients%20with%20hereditary%20transthyretin%20amyloidosis&amp;volume=379&amp;publication_year=2018&amp;pages=22-31&amp;pmid=29972757&amp;doi=10.1056/NEJMoa1716793&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16">
<span class="label">16.</span><cite>
Finn JD, Smith AR, Patel MC, et al. 
A Single Administration of CRISPR/Cas9 lipid nanoparticles achieves robust and persistent in vivo genome editing. Cell Rep
2018;22(9):2227–2235; doi: 10.1016/j.celrep.2018.02.014.</cite> [<a href="https://doi.org/10.1016/j.celrep.2018.02.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29490262/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Rep&amp;title=A%20Single%20Administration%20of%20CRISPR/Cas9%20lipid%20nanoparticles%20achieves%20robust%20and%20persistent%20in%20vivo%20genome%20editing&amp;volume=22&amp;issue=9&amp;publication_year=2018&amp;pages=2227-2235&amp;pmid=29490262&amp;doi=10.1016/j.celrep.2018.02.014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17">
<span class="label">17.</span><cite>
Wood K, Pink M, Seitzer J, et al.  Development of NTLA-2001, a CRISPR-Cas9 genome editing therapeutic for the treatment of ATTR. In: Presented at the Second European Congress for ATTR Amyloidosis. Berlin; September 1–3, 2019.</cite> [<a href="https://scholar.google.com/scholar_lookup?Wood%20K,%20Pink%20M,%20Seitzer%20J,%20et%20al.%20Development%20of%20NTLA-2001,%20a%20CRISPR-Cas9%20genome%20editing%20therapeutic%20for%20the%20treatment%20of%20ATTR.%20In:%20Presented%20at%20the%20Second%20European%20Congress%20for%20ATTR%20Amyloidosis.%20Berlin;%20September%201%E2%80%933,%202019." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18">
<span class="label">18.</span><cite>
Gillmore JD, Gane E, Taubel J, et al. 
CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. N Engl J Med
2021;385(6):493–502; doi: 10.1056/NEJMoa2107454.</cite> [<a href="https://doi.org/10.1056/NEJMoa2107454" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34215024/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=CRISPR-Cas9%20in%20vivo%20gene%20editing%20for%20transthyretin%20amyloidosis&amp;volume=385&amp;issue=6&amp;publication_year=2021&amp;pages=493-502&amp;pmid=34215024&amp;doi=10.1056/NEJMoa2107454&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19">
<span class="label">19.</span><cite>
Wang L, Smith J, Breton C, et al. 
Meganuclease targeting of PCSK9 in macaque liver leads to stable reduction in serum cholesterol. Nat Biotechnol
2018;36(8):717–725; doi: 10.1038/nbt.4182.</cite> [<a href="https://doi.org/10.1038/nbt.4182" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29985478/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Biotechnol&amp;title=Meganuclease%20targeting%20of%20PCSK9%20in%20macaque%20liver%20leads%20to%20stable%20reduction%20in%20serum%20cholesterol&amp;volume=36&amp;issue=8&amp;publication_year=2018&amp;pages=717-725&amp;pmid=29985478&amp;doi=10.1038/nbt.4182&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20">
<span class="label">20.</span><cite>
Wang L, Breton C, Warzecha CC, et al. 
Long-term stable reduction of low-density lipoprotein in nonhuman primates following in vivo genome editing of PCSK9. Mol Ther
2021;29(6):P2019–2029; doi: 10.1016/j.ymthe.2021.02.020.</cite> [<a href="https://doi.org/10.1016/j.ymthe.2021.02.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8178442/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33609733/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Ther&amp;title=Long-term%20stable%20reduction%20of%20low-density%20lipoprotein%20in%20nonhuman%20primates%20following%20in%20vivo%20genome%20editing%20of%20PCSK9&amp;volume=29&amp;issue=6&amp;publication_year=2021&amp;pages=P2019-2029&amp;pmid=33609733&amp;doi=10.1016/j.ymthe.2021.02.020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21">
<span class="label">21.</span><cite>
Breton C, Furmanak T, Avitto AN, et al. 
Increasing the specificity of AAV-based gene editing through self-targeting and short-promoter strategies. Mol Ther
2021;29(3):1047–1056; doi: 10.1016/j.ymthe.2020.12.028.</cite> [<a href="https://doi.org/10.1016/j.ymthe.2020.12.028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7934631/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33359790/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Ther&amp;title=Increasing%20the%20specificity%20of%20AAV-based%20gene%20editing%20through%20self-targeting%20and%20short-promoter%20strategies&amp;volume=29&amp;issue=3&amp;publication_year=2021&amp;pages=1047-1056&amp;pmid=33359790&amp;doi=10.1016/j.ymthe.2020.12.028&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22">
<span class="label">22.</span><cite>
Gao G, Lu Y, Calcedo R, et al. 
Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates. Mol Ther
2006;13(1):77–87; doi: 10.1016/j.ymthe.2005.08.017.</cite> [<a href="https://doi.org/10.1016/j.ymthe.2005.08.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16219492/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Ther&amp;title=Biology%20of%20AAV%20serotype%20vectors%20in%20liver-directed%20gene%20transfer%20to%20nonhuman%20primates&amp;volume=13&amp;issue=1&amp;publication_year=2006&amp;pages=77-87&amp;pmid=16219492&amp;doi=10.1016/j.ymthe.2005.08.017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23">
<span class="label">23.</span><cite>
Greig JA, Peng H, Ohlstein J, et al.  Intramuscular injection of AAV8 in mice and macaques is associated with substantial hepatic targeting and transgene expression. PLoS One
2014;9(11):e112268; doi: 10.1371/journal.pone.0112268.</cite> [<a href="https://doi.org/10.1371/journal.pone.0112268" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4230988/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25393537/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;publication_year=2014&amp;pmid=25393537&amp;doi=10.1371/journal.pone.0112268&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24">
<span class="label">24.</span><cite>
Calcedo R, Vandenberghe LH, Gao G, et al. 
Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses. J Infect Dis
2009;199(3):381–390; doi: 10.1086/595830.</cite> [<a href="https://doi.org/10.1086/595830" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10826927/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19133809/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Infect%20Dis&amp;title=Worldwide%20epidemiology%20of%20neutralizing%20antibodies%20to%20adeno-associated%20viruses&amp;volume=199&amp;issue=3&amp;publication_year=2009&amp;pages=381-390&amp;pmid=19133809&amp;doi=10.1086/595830&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25">
<span class="label">25.</span><cite>
Calcedo R, Chichester JA, Wilson JM. Assessment of humoral, innate, and T-cell immune responses to adeno-associated virus vectors. Hum Gene Ther Methods
2018;29(2):86–95; doi: 10.1089/hgtb.2018.038.</cite> [<a href="https://doi.org/10.1089/hgtb.2018.038" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29668327/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Gene%20Ther%20Methods&amp;title=Assessment%20of%20humoral,%20innate,%20and%20T-cell%20immune%20responses%20to%20adeno-associated%20virus%20vectors&amp;volume=29&amp;issue=2&amp;publication_year=2018&amp;pages=86-95&amp;pmid=29668327&amp;doi=10.1089/hgtb.2018.038&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26">
<span class="label">26.</span><cite>
Tsai SQ, Zheng Z, Nguyen NT, et al. 
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol
2015;33(2):187–197; doi: 10.1038/nbt.3117.</cite> [<a href="https://doi.org/10.1038/nbt.3117" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4320685/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25513782/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Biotechnol&amp;title=GUIDE-seq%20enables%20genome-wide%20profiling%20of%20off-target%20cleavage%20by%20CRISPR-Cas%20nucleases&amp;volume=33&amp;issue=2&amp;publication_year=2015&amp;pages=187-197&amp;pmid=25513782&amp;doi=10.1038/nbt.3117&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27">
<span class="label">27.</span><cite>
Breton C, Clark PM, Wang L, et al.  ITR-Seq, a next-generation sequencing assay, identifies genome-wide DNA editing sites in vivo following adeno-associated viral vector-mediated genome editing. BMC Genomics
2020;21(1):239; doi: 10.1186/s12864-020-6655-4.</cite> [<a href="https://doi.org/10.1186/s12864-020-6655-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7076944/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32183699/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Genomics&amp;publication_year=2020&amp;pmid=32183699&amp;doi=10.1186/s12864-020-6655-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28">
<span class="label">28.</span><cite>
Bell P, Moscioni AD, McCarter RJ, et al. 
Analysis of tumors arising in male B6C3F1 mice with and without AAV vector delivery to liver. Mol Ther
2006;14(1):34–44; doi: 10.1016/j.ymthe.2006.03.008.</cite> [<a href="https://doi.org/10.1016/j.ymthe.2006.03.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16682254/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Ther&amp;title=Analysis%20of%20tumors%20arising%20in%20male%20B6C3F1%20mice%20with%20and%20without%20AAV%20vector%20delivery%20to%20liver&amp;volume=14&amp;issue=1&amp;publication_year=2006&amp;pages=34-44&amp;pmid=16682254&amp;doi=10.1016/j.ymthe.2006.03.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29">
<span class="label">29.</span><cite>
Wang L, Calcedo R, Bell P, et al. 
Impact of pre-existing immunity on gene transfer to nonhuman primate liver with adeno-associated virus 8 vectors. Hum Gene Ther
2011;22(11):1389–1401; doi: 10.1089/hum.2011.031.</cite> [<a href="https://doi.org/10.1089/hum.2011.031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3225046/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21476868/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Gene%20Ther&amp;title=Impact%20of%20pre-existing%20immunity%20on%20gene%20transfer%20to%20nonhuman%20primate%20liver%20with%20adeno-associated%20virus%208%20vectors&amp;volume=22&amp;issue=11&amp;publication_year=2011&amp;pages=1389-1401&amp;pmid=21476868&amp;doi=10.1089/hum.2011.031&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30">
<span class="label">30.</span><cite>
Calcedo R, Wilson JM. AAV natural infection induces broad cross-neutralizing antibody responses to multiple AAV serotypes in Chimpanzees. Hum Gene Ther Clin Dev
2016;27(2):79–82; doi: 10.1089/humc.2016.048.</cite> [<a href="https://doi.org/10.1089/humc.2016.048" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4932656/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27314914/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Gene%20Ther%20Clin%20Dev&amp;title=AAV%20natural%20infection%20induces%20broad%20cross-neutralizing%20antibody%20responses%20to%20multiple%20AAV%20serotypes%20in%20Chimpanzees&amp;volume=27&amp;issue=2&amp;publication_year=2016&amp;pages=79-82&amp;pmid=27314914&amp;doi=10.1089/humc.2016.048&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31">
<span class="label">31.</span><cite>
Alnylam. Alnylam Reports Positive Topline Results from HELIOS-A Phase 3 Study of Vutrisiran in Patients with hATTR Amyloidosis with Polyneuropathy. Cambridge, MA; 2021. Available from: <a href="https://investors.alnylam.com/press-release?id=25366" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://investors.alnylam.com/press-release?id=25366</a> [Last accessed: July 6, 2022].</cite>
</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><span>Supplemental data</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9700363/bin/Supp_FigS1.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supp_FigS1.pdf</a><sup> (462.1KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p"><span>Supplemental data</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9700363/bin/Supp_FigS2.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supp_FigS2.pdf</a><sup> (516.4KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="caption p"><span>Supplemental data</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9700363/bin/Supp_FigS3.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supp_FigS3.pdf</a><sup> (376.1KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="caption p"><span>Supplemental data</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9700363/bin/Supp_FigS4.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supp_FigS4.pdf</a><sup> (450.5KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material5_reqid_"><div class="caption p"><span>Supplemental data</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9700363/bin/Supp_FigS5.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supp_FigS5.pdf</a><sup> (416KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material6_reqid_"><div class="caption p"><span>Supplemental data</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9700363/bin/Supp_FigS6.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supp_FigS6.pdf</a><sup> (400.7KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material7_reqid_"><div class="caption p"><span>Supplemental data</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9700363/bin/Supp_FigS7.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supp_FigS7.pdf</a><sup> (656.4KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material8_reqid_"><div class="caption p"><span>Supplemental data</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9700363/bin/Supp_FigS8.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supp_FigS8.pdf</a><sup> (532.5KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material9_reqid_"><div class="caption p"><span>Supplemental data</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9700363/bin/Supp_FigS9.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supp_FigS9.pdf</a><sup> (675.4KB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>All data discussed in the article are available in the main text or Supplementary Materials. Complete clinical pathology data can be obtained upon request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Human Gene Therapy are provided here courtesy of <strong>Mary Ann Liebert, Inc.</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1089/hum.2022.061"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/hum.2022.061.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (836.2 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/9700363/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/9700363/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9700363%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9700363/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC9700363/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC9700363/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/36375122/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC9700363/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/36375122/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC9700363/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/9700363/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="lGyoAAmVMsarShs42RRmucioakzLJum3mpl53lK7JOpXcKLpg5W2iQKYV8Plm43H">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
